Father’s 20-Year Battle on Behalf of Vaccine-Injured Son Exposes Travesty of Liability-Free Vaccines

From [CHD] In a riveting legal battle spanning two decades, William Yates Hazlehurst (“Yates”) on Feb. 2, 2022, became the first vaccine-injured person with a diagnosis of autism to reach a jury since the National Childhood Vaccine Injury Compensation Act of 1986 (the Vaccine Act) became law.

In a medical malpractice case filed in the Madison County Circuit Court in Tennessee, attorneys for Yates argued the clinic and physician who administered Yates’ vaccines, including the measles-mumps-rubella (MMR) vaccine on Feb. 8, 2001, should be held liable for medical malpractice and the neurological injuries Yates developed after being vaccinated.

Although the jury decided in favor of the physician — who Yates’ father said failed to adequately inform the parents of the risks of vaccinating Yates while he had an active ear infection — the case exposed major flaws in a system designed to protect children and shield pharmaceutical companies and physicians from liability for vaccine injuries.

“In the fight to end the autism epidemic, we were all hoping for the one knockout punch that would bring the truth to light and help end the autism epidemic,” Yates’ father, Rolf Hazlehurst, said.

“This medical malpractice trial was the only opportunity in the last 35 years for a jury to hear evidence in a court of law regarding whether a vaccine injury can cause neurological injury, including autism.”

Hazlehurst, who is a senior staff attorney for Children’s Health Defense (CHD), said “unless the Vaccine Act is repealed, my son is probably the only vaccine-injured child with a diagnosis of autism who will ever reach a jury.”

The Hazlehurst case was a medical malpractice case against the doctor who administered the pediatric vaccines that, in the opinion of the world’s top experts, sent Yates, now 22, spiraling into the depths of severe, non-verbal autism.

Although the case was originally filed in 2003, it didn’t receive its day in court for 19 years because a separate case involving Yates’ injury first had to work its way through the National Vaccine Injury Compensation Program (NVICP).

When Yates’ medical malpractice case was finally heard, the trial exposed alarming evidence about autism and vaccines, the low standard of care practiced by physicians administering pediatric vaccines and financial conflicts of interests between pharmaceutical companies that manufacture vaccines and government agencies entrusted with vaccine safety.

During the trial, the world’s top experts in the field of autism and mitochondrial disorderexplained how the administration of “routine” childhood immunizations can cause autism, brain injury, and many other disorders.

According to the National Institute of Mental Health, autism is a neurological and developmental disorder that affects how people interact with others, communicate, learn and behave. Symptoms can be severe and usually manifest before a child turns 3, which coincides with the age children receive the most childhood vaccines.

Increasing evidence indicates a significant proportion of individuals with autism have concurrent diseases such as mitochondrial dysfunction, abnormalities of energy generation, gastrointestinal abnormalities and abnormalities in the regulation of the immune system.

Yates’ medical malpractice trial illuminated how vaccines can cause autism in children with mitochondrial disorder and showed how the Vaccine Act — which is designed to ensure informed consent and compensation to injured children — is an abject failure because it’s largely unenforceable.

Yates was normal until he received his 12-month vaccines

During the first year of his life, Yates developed typically and met all of his developmental milestones.

“He was a happy, healthy and normal child,” his father said.

After his 6-month shots, Yates experienced a severe screaming episode approximately 24 hours after receiving the DTaP, Prevnar, Hib and Hep B vaccines.

In the days following his vaccinations, Yates began to experience seizure-like shaking episodes.

But his parents didn’t realize their son’s symptoms were consistent with a severe vaccine adverse reaction because they were not given a Vaccine Information Statement (VIS) at their pediatrician’s office.

According to the Centers for Disease Control and Prevention (CDC), a VIS is an information sheet produced by the CDC that explains both the benefits and risks of a vaccine to recipients.

Federal law requires that healthcare staff provide a VIS to a patient, parent or legal representative before each dose of certain vaccines,” the CDC website states.

Instead of providing the VIS, Yates’ physician told his parents any adverse event to a vaccine would be “almost immediate” — within 5 to 15 minutes after vaccination.

Before Yates’ first birthday, his mother and aunt took him to the doctor because he had been sick, and his parents wanted to make sure it was okay for Yates to have a birthday party.

Hazlehurst told The Defender this appointment was not a scheduled well-child check. It was a sick visit. At the appointment, Yates was diagnosed with an ear infection and prescribed an antibiotic.

As the pediatrician turned to leave, he stated Yates would receive his shots, as it was close to his first birthday. A woman returned to the room who portrayed herself to be a nurse, but Hazlehurst later found out was only a medical assistant.

Yates’ mother asked the “nurse” whether their son should receive his shots despite being sick and was told he should.

Once again, they were not given a VIS form informing them of the risks of vaccinating Yates while he had a fever and an active ear infection.

“By administering vaccines to a sick child, the doctor and his clinic could charge a “modified double bill” Hazlehurst said.

That day, on Feb. 8, 2001, Yates received the MMR, Prevnar, Hib and Hep B vaccines. Twelve days later, Hazlehurst said his son experienced a high fever, rash and vomiting consistent with a vaccine adverse reaction.

Hazlehurst called the clinic where his son received his vaccine and talked to the doctor on call who asked him which vaccines Yates received. Hazlehurst responded, “whatever you get when you’re a year old.”

Hazlehurst was told his son was having an adverse reaction to the antibiotic and the doctor wrote him a prescription for a different antibiotic and an anti-fungal medication.

Soon after, Yates began to lose the skills he once had and began developing abnormally. He lost his speech, started running wild, was constantly on the go and would knock things off the table.

“He was visually ‘stimming’ off the falling objects and running with his head down for the visual stimulation,” Hazlehurst said.

He explained:

“It was not like he got the shots and boom, the next day he was autistic. That’s not the way it happened. The mitochondria produce the energy to the connecting tissue in the cells in the brain, and if they don’t get enough energy for a short period of time (as short as 6 seconds), cellular death occurs.

“The brain keeps developing, but it cannot develop normally because the connecting cellular tissue has been damaged. That’s why it takes time to manifest. It’s like watching grass grow. It’s happening, but you don’t realize it’s happening.”

Yates’ condition worsened. He developed an obsession with spinning objects, became a picky eater, started hand-flapping and toe-walking, became unable to sleep and exhibited gastrointestinal and multiple other medical and neurodevelopmental issues, Hazlehurst said.

On June 3, 2002, Yates was diagnosed with autism spectrum disorder.

Hazlehurst searches for answers to his son’s autism

According to federal law, there are specific recording requirements for vaccine medical records, and healthcare providers must provide records to a parent upon request.

Hazlehurst, on June 21, 2002, requested a copy of his son’s original vaccine records so other physicians could evaluate, diagnose and treat Yates.

Hazlehurst had questions about the American Academy of Pediatrics’ standard of care and wanted to know why his son was vaccinated while he was sick with a fever.

In response to Hazlehurst’s request and questions about Yates’ care, the pediatrician rushed out of the room and called his attorney, Hazlehurst said.

The doctor and clinic denied Hazlehurst’s requests to review and receive copies of his son’s original vaccine records, forcing him to petition the court for Yates’ records.

The court granted the request, and the local sheriff’s department seized Yates’ medical records from the doctor’s clinic.

Hazlehurst quickly realized there were problems with his son’s vaccine record, which was on an unsigned consent form that had a billing code sticker placed over the language regarding the risks and benefits of vaccines and vaccine information materials.

Hazlehurst said he never received a VIS form and Yates had been vaccinated without informed consent.

Hazlehurst files claim with the NVICP for son’s vaccine injury

Hazlehurst, like many parents of vaccine-injured children, pursued a claim with the NVICP as federal law requires. The process took nine years — from 2002 to 2011.

In order to bring a case in a court of law, the parents of a vaccine-injured child must first file their case with the NVICP.

The NVICP is a special, no-fault tribunal housed within the U.S. Court of Federal Claims that handles injury claims for 16 federally recommended vaccines. To date, the court has awardedmore than $4 billion to thousands of people for vaccine injuries.

In the NVICP, America’s legal system is replaced by a “special master.” The special masters who review claims are government-appointed attorneys, many of whom are former U.S. Department of Justice (DOJ) attorneys.

Under the NVICP, the parents of vaccine-injured children are forced to sue the secretary of the U.S. Department of Health and Human Services (HHS) for compensation. HHS is represented by DOJ attorneys.

It is exceptionally difficult to obtain compensation within the NVICP, Hazlehurst said. The proceedings are often turned into drawn-out, contentious expert battles and the backlog of cases is substantial. Because of this, a single case can drag on for over a decade.

Payouts, including attorneys’ fees, are funded by a 75-cent tax per vaccine. There is a $250,000 cap on pain and suffering and death benefits.

The Vaccine Act established the NVICP, and the 2011 U.S. Supreme Court decision Bruesewitz et al v. Wyeth et al later guaranteed vaccine manufacturers, doctors and other vaccine administrators almost always have no legal accountability or financial liability in civil court when a government-recommended or mandated vaccine(s) causes permanent injury or death, Hazlehurst said.

The NVICP ultimately denied Yates’ claim, but his case against HHS became a central part of the U.S Supreme Court’s decision in Bruesewitz v. Wyeth.

Yates’ case in the NVICP was part of the Omnibus Autism Proceeding (OAP), in which 5,400 claims submitted to the NVICP were consolidated to determine if vaccines cause autism and if so, under what conditions.

“HHS whittled down the thousands of cases to six “test cases,” one of which was Yates’ case,” Hazlehurst said. “If HHS could find a way to deny NVICP compensation to the test cases, the agency would be able to deny compensation to all 5,400 families.”

Hazlehurst said HHS and the DOJ “took advantage of the fact that the rules of evidence, discovery and civil procedure mechanisms available in a regular court do not apply in the so-called vaccine court, and perpetrated fraud upon the special masters, the Court of Appeals for the D.C. Circuit and ultimately, the U.S. Supreme Court.”

The special masters on Feb. 12, 2009, in the so-called vaccine court, denied Yates’ petition for compensation and those of the five remaining OAP “test cases” involving children who developed autism after receiving their pediatric vaccines.

HHS makes key concession in Hannah Poling case

The potential fourth test case — Hannah Poling’s — was quietly conceded in 2007, in a corrupt coverup to conceal the opinion of the HHS expert witness, Dr. Andrew Zimmerman, the world’s leading expert in autism research, Hazlehurst said.

When Poling was 19 months old, she was vaccinated against nine diseases at one doctor’s visit: measles, mumps, rubella, polio, varicella, diphtheria, pertussis, tetanus and Haemophilus influenzae type b. In total, she received five vaccines.

Prior to receiving her vaccines, Poling was described as normal, happy, healthy, interactive, playful and communicative. But two days after being vaccinated, she was lethargic, irritable and febrile, and within 10 days she developed a rash consistent with vaccine-induced chicken pox.

Over the course of several months, Poling stopped eating, didn’t respond when spoken to, began showing signs of autism, developed neurological and psychological disorders and was diagnosed with encephalopathy caused by an underlying mitochondrial disorder.

In 2003, Poling’s father, Jon, a physician and trained neurologist, and mother, Terry, an attorney and nurse, filed an autism claim against HHS under the NVICP for their daughter’s injuries.

Five years later, the government settled the case before trial and in essence had it sealed.

During the OAP, in the Poling case, the government quietly conceded vaccines caused “regressive encephalopathy with features of autism spectrum disorder.”

According to CBS News, Poling received more than $1.5 million dollars for her life care, lost earnings and pain and suffering for the first year alone. After the first year, the family was supposed to receive more than $500,000 per year to pay for Poling’s care, which is estimated to amount to $40 million over her lifetime.

Jon Poling on March 6, 2008, said, “the results, in this case, may well signify a landmark decision with children developing autism following vaccinations.”

Prior to the Poling case, federal health agencies and professional organizations had reassured the public vaccines didn’t cause autism. The Poling case challenged that narrative, which is why the case was conceded and in essence sealed.

HHS’ concession that Poling developed autism as a result of a vaccine injury briefly became international news. Yet, only a handful of people knew why the government conceded Hannah’s case.

When news of the concession in Poling v. HHS was made public in March 2008, Dr. Julie Gerberding, then-director of the CDC, in an interview with CNN’s Dr. Sanjay Gupta said:

“We all know that vaccines can occasionally cause fevers in kids, so if a child was immunized, got a fever, had other complications from the vaccines, then if you are predisposed with a mitochondrial disorder, it can certainly set off some damage — some of the symptoms can be symptoms that have characteristics of autism.”

If HHS had not conceded her case, the truth as to how vaccines cause autism in some children with an underlying mitochondrial disorder would have been exposed by the world’s leading expert witnesses in the spotlight of the OAP, Hazlehurst said.

The concession document in the Poling case states:

“The vaccinations Hannah received on July 19, 2000, significantly aggravated an underlying mitochondrial disorder, which predisposed her to deficits in cellular energy metabolism, and manifested as a regressive encephalopathy with features of autism spectrum disorder.”

Zimmerman was an expert witness for the government defending vaccines in the NVICP. In 2007, during the hearing in the first test case, he told the government vaccines could cause autism in “exceptional” cases, but said the government later hid that information and misrepresented his expert opinion.

In a 2018 letter, Robert F. Kennedy, Jr., CHD chairman and chief legal counsel, and Hazlehurst meticulously described the DOJ’s fraud pertaining to the misrepresentation of Zimmerman’s opinions in the OAP and requested an investigation.

“The Office of Inspector General passed the buck to the DOJ Department of Ethics,” Hazlehurst said. “The DOJ investigated itself and wrote a highly misleading letter absolving itself of any wrongdoing.”

Zimmerman said in a signed affidavit:

“Shortly after I clarified my opinions with the DOJ attorneys, I was contacted by one of the junior DOJ attorneys and informed that I would no longer be needed as an expert witness on behalf of H.H.S. The telephone call … occurred after the above-referenced conversation on Friday, June 15, 2007, and before Monday, June 18, 2007. To the best of my recollection, I was scheduled to testify on behalf of H.H.S. on Monday, June 18, 2007.”

As a result of his firing, Zimmerman was not present for the Hazlehurst OAP proceedings, which allowed DOJ attorneys to misrepresent Zimmerman’s statements related to a separate autism case and apply them to all cases of autism, including Yates’ case.

Over the years Hazlehurst has repeatedly stated, “I want to be very clear, neither the Polings nor Dr. Zimmerman did anything wrong.”

“But,” he added, “if I did to a criminal, in a court of law, what the United States Department of Justice did to vaccine-injured children, I would be disbarred and I would be facing criminal charges.”

Zimmerman did testify as an expert witness on behalf of Yates in the medical malpractice case filed against Yates’ doctor, which was finally heard by a Tennessee court in February 2022.

Research by Zimmerman and others determined that at least 30%-40% of children with a diagnosis of regressive autism suffer from a mitochondrial disorder, which is a condition with which Yates was later diagnosed.

Yates in ‘perfect position’ to file lawsuit after exhausting remedies in NVICP

After exhausting all remedies under the NVICP — a process that took 25 years — the legal floodgates were then open, Hazlehurst said.

But because no one could sue the vaccine manufacturer, the only vaccine-injured child — out of thousands of cases originally included in the OAP — left with legal standing was Yates Hazlehurst and his claim of medical malpractice against the pediatrician who oversaw the administration of his vaccines.

Ultimately, the same medical experts, including Zimmerman and Dr. Richard Kelley, former director of the Genetics Department at Johns Hopkins Medical Institute  — whose testimony HHS and the DOJ relied on in the Poling concession — concluded that what happened to Hannah Poling is what also happened to Yates Hazlehurst.

In an affidavit which was not admissible in the 2022 medical malpractice trial, Kelley stated:

“I also find, with a high degree of medical certainty, that the set of immunizations administered to Yates at 11 months while he was ill was the immediate cause of his autistic regression because of the effect of these immunizations to further impair the ability of his weakened mitochondria to supply adequate amounts of energy for the brain, the highest energy-consuming tissue in the body.”

Zimmerman’s expert opinion on the cause of Yates’ neurological condition was consistent with Kelley’s opinion. [MORE]

New Research Demonstrates Wearing Masks May Make You Sick and Accumulating Research Shows Mask Mandates Didn't Lower the Spread of COVID, whether community spread of COVID was low or high

STORY AT-A-GLANCE

  • Using CDC data, no significant differences were found in COVID-19 case growth between states with or without mask mandates, during periods of low or high transmission

  • The widespread use of masks did not reduce COVID-19 transmission in Europe, and a moderate positive correlation was found between mask usage and deaths in Western Europe

  • An update to a CDC study on school mask mandates, using nearly six times more data, found no significant relationship between mask mandates in U.S. schools and COVID-19 case rates

  • In Kansas, counties with a mask mandate had significantly higher COVID-19 case fatality rates than counties without a mask mandate

  • One way masks cause harm may be the “Foegen effect” — the idea that deep re-inhalation of droplets and virions caught on facemasks might make COVID-19 infection more likely or more severe

From [MERCOLA] and [PDF] During the COVID-19 pandemic, 80% of U.S. states mandated masks to slow the spread of SARS-CoV-2, but accumulating research shows mask mandates and use do not lower the spread of the virus.1 While rules requiring masks did increase compliance, they didn't translate to lower transmission growth rates, whether community spread of SARS-CoV-2 was low or high.

Even before COVID-19 was declared a pandemic, mask mandates were put in place without ever properly evaluating efficacy, but that didn't stop them from dividing communities and being used as a form of virtue signaling and a visible reminder of compliance with the "new normal."

Now, with research showing not only that masks don't protect you but may actually make you sick, the rationale behind their widespread mandated usage must be questioned.

Mask Mandates Didn't Lower COVID-19 Cases

Using CDC data, researchers with the University of Louisville calculated total COVID-19 case growth and mask use for the U.S. No significant differences were found in case growth between mandate and non-mandate states during periods of low or high transmission.

"Surges were equivocal," they noted, concluding, "Mask mandates and use are not associated with slower state-level COVID-19 spread during COVID-19 growth surges."2 While stating that their findings "do not support the hypothesis that SARS-CoV-2 transmission rates decrease with greater public mask use," they did note that "masks may promote social cohesion as rallying symbols during a pandemic."3

Similarly dismal results from mask mandates were demonstrated in Europe. A study published in Cureus analyzed data from 35 European countries, including morbidity, mortality and mask usage, over a six-month period. The researchers noted:4

"Mask mandates were implemented in almost all world countries and in most places where masks were not obligatory, their use in public spaces was recommended … These mandates and recommendations took place despite the fact that most randomized controlled trials carried out before and during the COVID-19 pandemic concluded that the role of masks in preventing respiratory viral transmission was small, null, or inconclusive."

When the data were analyzed, the study also revealed that the widespread use of masks did not reduce COVID-19 transmission. Worse, a moderate positive correlation was found between mask usage and deaths in Western Europe, which "suggests that the universal use of masks may have had harmful unintended consequences."5

Mask Mandates in Schools Didn't Reduce COVID-19 Cases

As part of the government sponsored propaganda campaign, a widely cited CDC study, published in October 2021, reported that counties without school mask mandates had larger increases in COVID-19 case rates in children after the start of school compared with counties that had school mask mandates.6

The study was used to support school mask mandates, but a team of researchers revisited the research, incorporating a larger sample size and longer study period. The updated study,7 published in May 2022, used nearly six times more data compared to the original study and found no significant relationship between mask mandates in U.S. schools and COVID-19 case rates. According to the researchers:8

"We failed to establish a relationship between school masking and pediatric cases using the same methods but a larger, more nationally diverse population over a longer interval. Our study demonstrates that observational studies of interventions with small to moderate effect sizes are prone to bias caused by selection and omitted variables. Randomized studies can more reliably inform public health policy."

On Twitter, surgeon and public policy researcher Dr. Marty Makary pointed out that the CDC's original study appeared to include cherry-picked data and the agency refused to publish an update using the more extensive data:9

"This study demonstrates how the CDC was cherry-picking data to support their school mask dogma. The article states that CDC's MMWR journal rejected publishing this re-analysis. Most likely because it exposed the CDCs salami-slicing of data & use of science as political propaganda."

It should be noted that a previous CDC study found mask requirements for students had little effect on COVID-19 incidence in Georgia schools, while improved ventilation, such as opening a window, reduced cases more than mask mandates for staff and teachers.10

The Foegen Effect: Mask Mandates Increased COVID-19 Deaths

A profoundly important study was conducted by German physician Dr. Zacharias Fögen to find out whether mandatory mask use influenced the COVID-19 case fatality rate in Kansas from August 1, 2020, to October 15, 2020.11 He chose the state of Kansas because, while it issued a mask mandate, counties were allowed to either opt in or out of it.

His analysis revealed that counties with a mask mandate had significantly higher case fatality rates than counties without a mask mandate. "These findings suggest that mask use might pose a yet unknown threat to the user instead of protecting them, making mask mandates a debatable epidemiologic intervention," he concluded.

That threat, he explained, may be something called the "Foegen effect" — the idea that deep re-inhalation of droplets and virions caught on facemasks might make COVID-19 infection more likely or more severe.

“The fundamentals of this effect are easily demonstrated when wearing a facemask and glasses at the same time by pulling the upper edge of the mask over the lower edge of the glasses. Droplets appear on the mask when breathing out and disappear when breathing in.”

"In the "Foegen effect," the virions spread (because of their smaller size) deeper into the respiratory tract. They bypass the bronchi and are inhaled deep into the alveoli, where they can cause pneumonia instead of bronchitis, which would be typical of a virus infection. 

Furthermore, these virions bypass the multilayer squamous epithelial wall that they cannot pass into in vitro and most likely cannot pass into in vivo. Therefore, the only probable way for the virions to enter the blood vessels is through the alveoli."12

Wearing Masks Could Be Related to Long COVID

Fögen explained that wearing masks could end up increasing your overall viral load because, instead of exhaling virions from your respiratory tract and ridding your body of them, those virions are caught in the mask and returned. This might also have the effect of increasing the number of virions that pass through the mask, such that it becomes more than the number that would have been shed without a mask.

The fact that "hypercondensed droplets and pure virions in the mask might be blown outwards during expiration, resulting in aerosol transmission instead of droplet transmission" is another issue that could make transmission worse instead of better, and the use of "more protective" masks could also backfire, making COVID-19's long-term effects worse. Fögen explained:13

"The use of "better" masks (e.g., FFP2, FFP3) with a higher droplet-filtering capacity probably should cause an even stronger "Foegen effect" because the number of virions that are potentially re-inhaled increases in the same way that outward shedding is reduced.

Another salient point is that COVID-19-related long-term effects and multisystem inflammatory syndrome in children may all be a direct cause of the "Foegen effect." Virus entry into the alveoli and blood without being restricted to the upper respiratory tract and bronchi and can cause damage by initiating an (auto) immune reaction in most organs."

Clear Risks of Prolonged Mask Use

Two expert reports spoke out against the use of masks for children in 2021. The first, a psychology report,14 stated that masks are likely to be causing psychological harm to children and interfering with development.15 "The extent of psychological harm to young people is unknown," the report stated, "due to the unique nature of the 'social experiment' currently underway in schools, and in wider society."16

The second report focused on health, safety and well-being,17 noting potential permanent physical damage to the lungs caused by fibrosis from inhalation of fibrous nanoparticles.

"There are real and significant dangers of respiratory infection, oral health deterioration and of lung injury, such as pneumothorax, owing to moisture buildup and also exposure to potentially harmful levels of an asphyxiant gas (carbon dioxide [CO2]) which can cause serious injury to health," the authors explained.18

Normally, the CO2 then dissipates into the air around you before you take another breath. In the open air, carbon dioxide typically exists at about 400 parts per million (ppm), or 0.04% by volume.

The German Federal Environmental Office set a limit of CO2 for closed rooms of 2,000 ppm, or 0.2% by volume. If you're wearing a facemask, the CO2 cannot escape as it usually does and instead becomes trapped in the mask. In a study published in JAMA Pediatrics, researchers analyzed the CO2 content of inhaled air among children wearing two types of masks, as well as wearing no mask.19

While no significant difference in CO2 was found between the two types of masks, there was a significant elevation when wearing masks compared to not wearing them. CO2 in inhaled air under surgical and filtering facepiece masks came in between 13,120 ppm and 13,910 ppm, "which is higher than what is already deemed unacceptable by the German Federal Environmental Office by a factor of 6," the researchers noted.20

Also important, this level was reached after only three minutes, while children wear masks at school for a mean of 270 minutes at a time. Even the child who had the lowest measured CO2 level had a measurement three-fold greater than the closed room CO2 limit of 0.2%. However, younger children appeared to have the highest CO2 values; a level of 25,000 ppm was measured from a 7-year-old wearing a facemask.21

Bacterial Infection Risk, Problems With Social Learning

The full consequences of prolonged mask use are only beginning to be understood. The University of Louisville researchers noted, however, that using a mask for more than four hours per day "promotes facial alkalinization and inadvertently encourages dehydration, which in turn can enhance barrier breakdown and bacterial infection risk."22 Other reported adverse effects include:23

After a lawsuit was brought by Leslie Manookian's Health Freedom Defense Fund (HFDF), U.S. District Judge Kathryn Kimball Mizelle finally voided the CDC's U.S. mask mandate on airplanes and public transit in April 2022.24 The U.S. Department of Justice (DoJ) has appealed the court order,25however, making it clear that they don't intend to give up on mask mandates without a fight. In response, HFDF issued the following statement:26

"DoJ's statement [that it would appeal] is perplexing to say the least and sounds like it comes from health policy advocates not government lawyers. The ruling by the US District Court ruling is a matter of law, not CDC preference or an assessment of 'current health conditions.'

If there is in fact a public health emergency with clear and irrefutable science supporting CDC's mask mandate, does it not warrant urgent action? Why would DoJ and CDC not immediately appeal?

HFDF is left with no option but to conclude that the Mask Mandate is really a political matter and not at all about urgent public health issues or the demands of sound science. While DoJ and CDC play politics with Americans' health and freedoms, HFDF trusts individual Americans to make their own health decisions.

HFDF is confident that Americans possess ample common sense and education to understand that there are real questions about mask efficacy and risk and that CDC's policy reflects neither."

You can support the Health Freedom Defense Fund and push back against the DoJ and CDC by taking to social media. Please follow and/or like the HFDF on the following platforms, share their content, and invite your followers to do the same:


Sources and References

FDA Grants Emergency Use Authorization for Novavax COVID Shots - Linked to Heart Inflammation, Blood Clots. Biden Purchased $3B of Shots Designed for the Original Variant, which has been Supplanted

THE BLIGHT HOUSE PROMISES TO LIE TO YOU OVER AND OVER.

From [CHD] The U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA)for the Novavax COVID-19 vaccine for adults 18 and over.

The EUA is for the two-dose primary series targeting the original Wuhan SARS-CoV-2 virus — limiting the vaccine’s use, as about two-thirds of Americans already have completed a primary series of either the Pfizer, Moderna or Johnson & Johnson vaccines.

The Centers for Disease Control and Prevention (CDC) still needs to sign off on the Novavax vaccine before pharmacies and other healthcare providers can start administering shots.

The vaccine maker’s stock rose 3% earlier today, after Politico reported yesterday that the FDA would likely announce the decision today.

The Biden administration on Monday announced a deal with Novavax to purchase 3.2 million doses of the vaccine.

Under the taxpayer-funded deal — which the U.S. Department of Health and Human Services said was contingent on the vaccine receiving EUA and formal recommendation by the Centers for Disease Control and Prevention — the U.S. government will provide the vaccine to states, jurisdictions, federal pharmacy partners and federally qualified health centers.

Advisors to the FDA last month recommended the agency accept Novavax’s EUA application, but the agency delayed issuing the authorization pending FDA review of the Maryland-based company’s manufacturing process.

Novavax already is available in other countries, including Canada and Australia, under the name Nuvaxovid.

The Novavax vaccine relies on a protein-based technology used for decades, leading some media outlets to portray it as a “traditional” vaccine compared with other COVID-19 vaccines that use newer technologies.

Politico reported last month that FDA committee members expressed interest in making available a vaccine that uses a different technology than the mRNA vaccines widely used in the U.S., “in hopes of convincing unvaccinated holdouts to change their minds.”

According to Politico, Novavax “may appeal to the sliver of the population allergic to components of the messenger RNA vaccines developed by Pfizer-BioNTech and Moderna, or who are skeptical of those shots’ newer technology.”

But according to Dr. Meryl Nass, an internist with a special interest in vaccine-induced illnesses, chronic fatigue syndrome and toxicology, the media’s portrayal of Novavax as a more traditional vaccine is not accurate.

Nass, a member of the Children’s Health Defense (CHD) scientific advisory committee, pointed out that the Novavax shot contains a novel adjuvant, Matrix-M, “so it is not really an old-fashioned shot.”

Nass raised safety concerns specific to the adjuvant, while others voiced concerns about Novavax being linked to heart inflammation and blood clots, and the fact that the vaccine was designed for use against the original Wuhan strain of SARS-CoV-2 — not the various Omicron variants that are dominant today.

How does Novavax differ from other COVID vaccines used in U.S.?

Novavax is a subunit protein vaccine. It uses the spike protein, which it delivers directly to the host cell, from the viral coat of the SARS-CoV-2 virus, as the antigen — the part of the vaccine that provokes an immune response.

The mRNA-based shots — Pfizer and Moderna — use a lipid nanoparticle to encapsulate the mRNA and usher it into the host cell. Then the host cell’s own machinery produces the spike protein.

“Unlike mRNA vaccines, the spike protein is already premade in the Novavax vaccine, said Dr.  Diana Florescu, who led the Novavax clinical trial. “It’s a shortcut. All the synthesis happens outside the body and we just give the end product: the spike protein.”

Johnson & Johnson’s Janssen COVID-19 shot is a viral vector vaccine. It also causes cells to produce the spike protein, but in a different way than the mRNA shots. It uses a virus called adenovirus, familiar as a common cause of respiratory infections.

The DNA in the adenovirus is modified so that when it enters the host cell, it causes the cell’s own machinery to produce the spike protein.

The adenovirus is also modified so it cannot replicate itself, which is why it is called a replication-defective recombinant adenoviral vector vaccine.

Adjuvant used in Novavax linked to autoimmune disease

Because Novavax is a protein subunit vaccine, it uses just the spike protein as the antigen rather than the whole pathogen (an inactivated or attenuated virus). Using the whole pathogen would expose the host to the virus’ entire protein coat instead of just one protein.

Protein subunit vaccines are often less immunogenic (less likely to provoke the immune system) than vaccines that use whole pathogens as the antigen, and may not generate a strong enough immune response.

That’s why they require the use of an adjuvant — in this case, Matrix-M — in addition to the antigen to get a stronger immune response.

However, few adjuvants are both potent and non-toxic enough for clinical use.

The proposed primary series for Novavax is two intramuscular injections 21 days apart at the dose level of 5 µg of the recombinant spike protein and 50 µg of the Matrix-M adjuvant.

Matrix-M, originally called QS-21, was one of the saponins derived from Quillaja saponaria, which is the soap bark tree native to Chile.

Some reports point out that the Matrix-M adjuvant — unlike the polyethylene glycol (PEG) lipidused in mRNA vaccines — is not linked to anaphylaxis (a severe allergic reaction), making it more attractive to people who are allergic to PEG.

But according to Nass, while it’s true that Matrix-M — which is not found in any other vaccines in the U.S. — isn’t linked to anaphylaxis, it is linked to autoimmune diseases.

“While touted as a replacement for the PEG lipid found in the mRNA vaccine, Matrix-M is less likely to cause anaphylaxis but more likely to cause autoimmune diseases,” Nass said.

Nass voiced other safety concerns about Novavax technology, including the use of moth cells.

According to the University of Nebraska Medical Center, where Novavax Phase 3 clinical trialswere conducted, the Novavax vaccine uses moth cells to create a nanotechnology version of the COVID-19 spike protein.

Nass said insect cells can be used to grow proteins rapidly. “There is one flu vaccine made the same way: Flublok,” Nass said. Flublok is one of two egg-free flu vaccines licensed for use in the U.S.

“How many insect and viral proteins or other molecules are being injected into you when you get the Novavax vaccine — which is a function of how purified the vaccine is —  is unknown,” Nass said.

Novavax still uses the spike protein

The SARS-CoV-2 virus encodes 29 proteins, but Novavax — like Pfizer, Moderna and Johnson & Johnson — chose to target only the spike protein.

As previously reported in The Defender, it is not known if the spike protein itself is safe.

“We have known for a long time that the spike protein is a pathogenic protein,” said Byram Bridle, Ph.D., assistant professor of immunology at the University of Guelph, Ontario. “It is a toxin. It can cause damage to our body if it gets into circulation.”

According to Brian Hooker, Ph.D., CHD’s chief scientific officer, “If you wanted to pick the most toxic protein, you know what represents the highest virulence, the highest amount of damage on the COVID-19 virus? You would pick the spike protein.”

The spike protein “has been consistently shown to create clotting issues in the blood,” Hooker said.

Novavax downplays link to heart issues

According to the briefing document for the Vaccines and Related Biological Products Advisory Committee meeting on June 7, severe local adverse events occurred in 1.2 to 7.2% of Novavax recipients, and systemic adverse events occurred in 2.4% to 12.1% of Novavax recipients.

These adverse events were more frequent after the second dose than after the first dose.

As previously reported in The Defender, there are concerns that Novavax is associated with myocarditis and pericarditis, just like the mRNA vaccines.

Reuters reported that the FDA asked Novavax to “flag” myocarditis and pericarditis as an “important identified risk” in its materials accompanying the vaccine. It is not known if the vaccine maker agreed to do so.

Novavax denied the connection between its vaccine and the reported cases of heart inflammation, claiming that “natural background events” of myocarditis can be expected in any large database.

“Based on our interpretation of all the clinical data supporting NVX-CoV2373 [Novavax]… we believe there is insufficient evidence to establish a causal relationship,” Novavax stated.

Does it work against the Omicron variant?

Like the other COVID-19 vaccines available in the U.S., Novavax’s vaccine was developed against the ancestral Wuhan strain of SARS-CoV-2.

In the FDA’s June 7 briefing document on the vaccine’s efficacy and safety, the FDA stated:

“The study enrollment and efficacy follow-up occurred during December 27, 2020, to September 27, 2021, and mainly when the Alpha variant of SARS-CoV-2 was predominant and prior to the emergence of Delta and Omicron variants.

“Relevant data to assess effectiveness of NVX-CoV2373 [Novavax] against the Omicron variant and sublineages, including observational data from use in other countries where the vaccine has been deployed, are currently unavailable; however, based on the efficacy estimate in the clinical trial of this vaccine, it is more likely than not that the vaccine will provide some meaningful level of protection against COVID-19 due to Omicron, in particular against more severe disease.”

The FDA briefing document also stated that due to the limited length of follow-up, “it is not currently possible to assess sustained efficacy over a period longer than 2 months.”

Bruce Gellin, chief of global public health strategy at the Rockefeller Foundation, was the lone abstaining vote on the FDA committee that voted to recommend Novavax on June 7.

Gellin said he abstained because the committee wasn’t given data on how the vaccine performs against the current Omicron variants, or for how many months its protection lasts.

Will Novavax convince the unvaxxed?

CNET last month reported that more than two years into the pandemic, a majority of Americans (about 67%) are fully vaccinated against COVID-19, and many have been boosted.

Kaiser Family Foundation poll found 75% of adult Americans self-report that they are already vaccinated.

Meanwhile, those hesitant or opposed to COVID-19 vaccination seem to be firm and consistent in their opinion, according to the Kaiser poll.

Kaiser has tracked the “public’s attitudes and experiences with COVID-19 vaccinations” since December 2020. During that time, the percentage of American adults who answered the poll and said they would “definitely not” get vaccinated ranged from 12% to 17%.

In April, the most recent month reported, 17% of those polled said they would “definitely not” get vaccinated against COVID-19.

Millions of Americans have already been infected with COVID-19 and recovered. As of February 2022, the overall seroprevalence rate (indicating previous COVID-19 infection) in the U.S., determined by random antibody testing, was 57%.

Emails Confirm Vaccine Definition was Changed b/c COVID Shots Aren’t “Vaccines.” [“Immunity” was Removed from Definition. Shots are a “Treatment” and People have a Right to Refuse “Medical Treatment”]

From [HERE] and [HERE] Newly obtained emails confirm that the Centers for Disease Control and Prevention (CDC) changed its definition for both “vaccine” and “vaccinated” because people were pointing out that definitions didn’t seem to apply to the COVID-19 vaccines.

“The definition of vaccine we have posted is problematic and people are using it to claim the COVID-19 vaccine is not a vaccine based on our own definition,” Alycia Downs, a CDC official, wrote in an email on Aug. 25, 2021, to a colleague.

The definition is located on a page titled Immunization Basics.

“Vaccine” was defined since at least 2011 by the CDC as a product that triggers immunity, while “vaccination” was described as an injection that prevents a disease, according to archived versions of the page. However, a flood of inquiries on the definitions was triggered by the fact that the COVID-19 vaccines have been increasingly ineffective against infection by the virus that causes COVID-19, the emails show.

“Our question is how is the CDC and the rest of the world allowed to call the shot a vaccination when it doesn’t even meet your own definition,” one person wrote to the CDC.

“Right-wing covid-19 pandemic deniers are using your ‘vaccine’ definition to argue that mRNA vaccines are not vaccines,” another said.

The Pfizer and Moderna COVID-19 vaccines are both built on messenger RNA technology. They are two of the three COVID-19 vaccines available in the United States.

Downs and colleagues Allison Michelle Fisher, Cynthia Jorgensen, Valerie Morelli, and Andrew (no last name given) worked on changing the definitions for “vaccine” and “vaccination,” according to the emails. [MORE]

A recently filed lawsuit funded by a renowned IP underwriter and analyst Dr. David Martin challenging the CMS federal mandate explains the importance of the definition vaccine and the legal distinction between vaccine and treatment because it triggers a much higher and stricter level of judicial review of mandates. The complaint in relevant part states "the CMS Mandate must be struck down because:

  • The overwhelming evidence shows that the Injections do not prevent transmission, infection, or reinfection in those who receive them.

  • The CDC Director has admitted that the Injections do not prevent infection or transmission of SARS-CoV-2, the virus that has been identified by various public health agencies as causing the disease known as COVID-19. “[W]hat [the vaccines] can’t do anymore is prevent transmission.”1

  • The CDC has acknowledged that the “vaccinated” and “unvaccinated” are equally likely to spread the virus.2 The Injections do not confer immunity but are claimed to reduce the severity of symptoms experienced by those infected by SARS-CoV-2. They are, therefore, treatments and not vaccines as that term has always been defined in the law.

  • In fact, the CDC has actually changed its definitions of “vaccine” and “vaccination” so that the Injections would fit within the new definition. Until recently, the Centers for Disease Control defined a “Vaccine” as: “A product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease.”3

  • The CDC also previously defined “Vaccination” as: “The act of introducing a vaccine into the body to produce immunity to a specific disease.”4

  • Both prior definitions fit the common understanding of those terms. To be vaccinated meant that the recipient should have lasting, robust immunity to the disease targeted by the vaccine.

  • But on September 1, 2021, the CDC quietly rewrote these definitions. It changed the definition of a “Vaccine” to: “A product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease preparation that is used to stimulate the body’s immune response against diseases.”5 It changed the definition of “Vaccination” to: “The act of introducing a vaccine into the body to produce immunity to protection from a specific disease.”6

  • Thus, the CDC has eliminated the word “immunity” from its definitions of “Vaccine” and “Vaccination.” Upon information and belief, the CDC did so because it recognizes that the Injections do not produce immunity to the disease known as COVID-19.

  • This is a critical factual and legal distinction. The Supreme Court has long held that the right to refuse medical treatment is a fundamental human right. Since the Injections do not stop the transmission of SARS-CoV-2 as a matter of fact, they are not “vaccines” as a matter of law. Instead, they are a therapeutic or medical treatment which Dr. Griner has the fundamental human right to refuse.

The complaint further explains,

The complaint explains,

“Because the Injections are treatments, and not vaccines, strict scrutiny applies. The US Supreme Court has recognized a “general liberty interest in refusing medical treatment.” Cruzan v. Dir., Mo. Dep’t of Health, 497 U.S. 261, 278, 110 S. Ct. 2841, 2851, 111 L.Ed.2d 224, 242 (1990). It has also recognized that the forcible injection of medication into a nonconsenting person’s body represents a substantial interference with that person’s liberty. Washington v. Harper, 494 U.S. 210, 229, 110 S. Ct. 1028, 1041, 108 L.Ed.2d 178, 203 (1990), see also id. at 223 (further acknowledging in dicta that, outside of the prison context, the right to refuse treatment would be a “fundamental right” subject to strict scrutiny).32

As mandated medical treatments are a substantial burden, Defendants must prove that the CMS Mandate is narrowly tailored to meet a compelling interest.

No such compelling interest exists because, as alleged above, the Injections are not effective against the now dominant Omicron variant of SARS-CoV-2 in that they do not prevent the recipient from becoming infected, getting reinfected, or transmitting SARS-CoV-2 to others. Indeed, evidence shows that vaccinated individuals have more SARS-CoV-2 in their nasal passages than unvaccinated people do.

The Injections may have been somewhat effective against the original SARS-CoV- 2 strain, but that strain has come and gone, and the Injections—designed to fight yesterday’s threat—are simply ineffective against the current variant.

Since the Injections are ineffective against the Delta and Omicron viral variants, and the original variant has been supplanted, there can be no compelling interest to mandate their use at this time.”

But even if there were a compelling interest in mandating the Injections, the CMS Mandate is not narrowly tailored to achieve such an interest.

The blanket mandate ignores individual factors increasing or decreasing the risks that the plaintiff—indeed, all healthcare workers—pose to themselves or to others.

Defendants entirely disregard whether employees have already obtained natural immunity despite the fact that natural immunity does actually provide immunity whereas the Injections do not.

Treating all employees the same, regardless of their individual medical status, risk factors, and natural immunity status is not narrowly tailored.

Moreover, the CMS Mandate fails entirely to consider other existing treatment options beyond the Injections as part of a more narrowly tailored approach. 97. Given these facts, as more fully set forth above, the CMS Mandate has no real or substantial relation to public health or is beyond all question, a plain, palpable invasion of rights secured by the fundamental law. Alternatively, the CMS Mandate has no real or substantial relation to public health or is beyond all question, a plain, palpable invasion of rights secured by the fundamental law as to Plaintiff, who already has natural immunity.” [MORE]

While Boris Johnson was "Resigning," a UK Government Report Revealed that 94% of all COVID Deaths in April and May 2022 were Among the Fully Vaccinated and 90% were Triple or Quadruple-Jabbed

From [EXPOSE] and [MERCOLA] While eyes around the world were focusing on British Prime Minister Boris Johnson’s resignation, a report on COVID-19 cases and deaths was quietly issued in the U.K., and now it’s raising eyebrows.

According to the U.K. Office for National Statistics, 94% of all COVID deaths in April and May 2022 were among fully vaccinated individuals. Not only that, 90% were triple- or quadruple-jabbed.

“It’s times like these that you ought to watch what bad news is being quietly published in the background in the hope that it won’t receive much attention, and it just so happens that hours before Boris announced his resignation, his government published new data that proves things have been terrible for the vaccinated population in England over the past couple of months,” The Exposé said.

In total, there were 4,935 COVID deaths, and 4,647 were considered fully vaccinated. Of those deaths, 4,216 were triple-jabbed. On the flip side, only 288 deaths were recorded among those who had not received the shots.

The following chart shows the real world Covid-19 vaccine effectiveness among the triple vaccinated population in England in the Week 3Week 7 and Week 13 UKHSA Vaccine Surveillance reports of 2022 –

This was nowhere near the claimed 95% effectiveness by Pfizer was it?

But now we have more evidence to both prove the UKHSA was lying, and that the current mainstream media storm surrounding the resignation of Boris Johnson is just a distraction.

This is because another UK Government agency, known as the Office for National Statistics (ONS), has just published data on deaths by vaccination status. 

The latest dataset from the ONS is titled ‘Deaths by Vaccination Status, England, 1 January 2021 to 31 May 2022‘, and it can be accessed on the ONS site here, and downloaded here.

Table 1 of the latest dataet contains figures on the mortality rates by vaccination status for all cause deaths, deaths involving Covid-19, and deaths not involving Covid-19. And it is here that we are able to ascertain the vaccination status of everyone who has died of Covid-19 since the beginning of April 2022, when the UKHSA claimed they could no longer reliably report the figures. 

Here’s how the ONS presents the figures for the month of April 2022 –

We’ve taken the figures provided by the ONS for both April and May 2022, and produced the following chart showing Covid-19 deaths by vaccination status in England between 1st April and 31st May 2022 – 

In all, according to the ONS, there were 4,935 Covid-19 deaths over these two months, and the vaccinated population accounted for a shocking 4,647 of those deaths. But what’s even more shocking is that the triple vaccinated accounted for 4,216 of those deaths, with just 288 deaths recorded among the unvaccinated population. 

In March 2022, there were 321 Covid-19 deaths within 60 days of a positive test among the unvaccinated population according to the UKHSA Week 13 Vaccine Surveillance Report, as detailed in the following chart using data extracted from table 13b of the report –

This means there were 33 less deaths among the unvaccinated over two months (April and May) than there were in the whole of March. 

Unfortunately, the opposite is true for the vaccinated population, especially the triple vaccinated. There were 911 more deaths among the vaccinated over two months, and 1,161 more death among the triple vaccinated. 

This means deaths have fallen drastically among the unvaccinated but increased significantly among the vaccinated population since the UKHSA claimed they could no longer reliably publish the data. 

The following chart shows the percentage of Covid-19 deaths by vaccination status in England between 1st April and 31st May 2022, according to the latest ONS dataset published just hours before Boris Johnson’s resignation –

The quietly published figures reveal that the vaccinated population as a whole accounted for a shocking 94% of all Covid-19 deaths in April and May 2022, with the unvaccinated accounting for just 6% of all Covid-19 deaths. But the most horrific statistic here is that 90% of the deaths among the vaccinated were among people who had been given at least three doses of a Covid-19 injection. 

However, many in the UK have been given a fourth dose of a Covid-19 injection since the spring, and judging by the latest data from the Government of Cananda, it’s likely many of those deaths could actually be among the quadruple vaccinated.

The most recent Government of Canada figures show that there were 521 Covid-19 deaths between 6th and 12th June, and the vaccinated population accounted for 485 of them, with a shocking 242 deaths among the quadruple vaccinated population, meaning they accounted for 50% of Covid-19 deaths among the vaccinated in the second week of June 2022. 

These aren’t the kind of figures you would expect to see if the Covid-19 injections really are up to 95% effective at preventing death, are they? [MORE]

Canadian Gov Data Shows that in June 2022, the Vaccinated Accounted for 93% of all COVID Deaths; 50% of which were Quadruple Jabbed

From [EXPOSE] The following chart shows the number of Covid-19 cases across the whole of Canada by vaccination status between 6th June and 12th June 2022 – 

the most recent figures show that there were 17,904 Covid-19 cases between 6th and 12th June, and the vaccinated population accounted for 17,040 of them, with 13,147 cases among the quadruple vaccinated population.

This means the unvaccinated population accounted for 5% of Covid-19 cases, whilst the vaccinated population accounted for 95%, 77% of which were among the quadruple jabbed.

Covid-19 Hospitalisations

The following chart shows the number of Covid-19 hospitalisations across the whole of Canada by vaccination status between 6th June and 12th June 2022 –

The most recent figures show that there were 1,041 Covid-19 hospitalisations between 6th and 12th June, and the vaccinated population accounted for 938 of them, with 694 hospitalisations among the quadruple vaccinated population.

This means the unvaccinated population accounted for 10% of Covid-19 hospitalisations, whilst the vaccinated population accounted for 90%, 74% of which were among the quadruple jabbed.

Covid-19 Deaths

The following chart shows the number of Covid-19 deaths across the whole of Canada by vaccination status between 6th June and 12th June 2022 –

The most recent figures show that there were 521 Covid-19 deaths between 6th and 12th June, and the vaccinated population accounted for 485 of them, with a shocking 242 deaths among the quadruple vaccinated population, and 200 deaths among the triple vaccinated population. 

This means the unvaccinated population accounted for just 7% of Covid-19 deaths, whilst the vaccinated population accounted for 93%, 50% of which were among the quadruple jabbed, and 41% of which were among the triple jabbed. 

Despite a mass booster campaign, and the Government of Canada trying to desperately conceal it, a bit of time, effort, and simple maths has revealed that 9 in every 10 Covid-19 cases, hospitalisations and deaths were recorded among the fully vaccinated population between 6th and 12th June 2022, and the vast majority of those were among the quadruple jabbed.

Should we really be seeing this if the Covid-19 injections are effective? 

Absolutely not. These figures suggest the more jabs you have, the more likely you are to be hospitalised or lose your life if exposed to the alleged Covid-19 virus.

FDA Quietly Grants Full Approval of Comirnaty Vax for Teens. Yet, It's not available in the US and Not the Same Formula as the Emergency Authorized Vax Falsely being Distributed as “fully approved”

From [CHD] The U.S. Food and Drug Administration (FDA) on Friday granted full approval of Pfizer-BioNTech’s Comirnaty COVID-19 vaccine for adolescents 12 through 15 years old.

In an FDA press release, the agency said full approval of Comirnaty follows a “rigorous analysis and evaluation of the safety and effectiveness data,” and the Pfizer-BioNTech vaccine “has been, and will continue to be authorized for emergency use in this age group since May 2021.”

Pfizer’s press release announcing the approval said the Comirnaty vaccine has been available under Emergency Use Authorization (EUA) since May 2021 for the adolescent age group.

Yet, Comirnaty is not available in the U.S for any age group and is not the same formula as the Pfizer-BioNTech vaccine currently authorized under EUA and being distributed as a “fully approved” vaccine.

“The approval of Comirnaty for adolescents 12 to 15 is head-spinning,” said Mary Holland, president and general counsel for Children’s Health Defense.

Holland added:

“The FDA failed to convene an expert committee and failed to appropriately weigh the risk-benefit profile of this vaccine for this age group. Even Vaccine cheerleader Dr. Paul Offit acknowledged FDA decisions are being made based on political pressure, not science when, in commenting on the agency’s vote last week to allow reformulated booster shots, he said it felt like ‘the fix was in.’”

Holland said that at base, “this is a move by pharma to ensure liability protection” under the National Childhood Vaccine Injury Act of 1986. Some states likely will attempt to put Comirnaty on the childhood vaccine schedule, despite the myriad known and unknown risks, Holland said.

“Pfizer‘s fraud and collusion with government is becoming more evident by the day,” Holland said. “CHD, already challenging the authorizations for those six months through age 11, will be at the forefront of challenging this approval for teenagers.”

Efficacy claims based on old analysis of 16- to 25-year-olds — before Delta, Omicron variants

Pfizer said Friday’s approval is based on data from a Phase 3 clinical trial of 2,260 participants ages 12 through 15.

About half of the participants, “elicited SARS-CoV-2–neutralizing antibody geometric mean titers (GMTs)” demonstrating “strong immunogenicity in a subset of adolescents one month after the second dose,” Pfizer said.

It is unknown what happened to antibody levels after one month, but peer-reviewed researchsuggests vaccine protection conferred by second and third doses of Pfizer’s COVID-19 vaccine wanes rapidly against the Omicron variant.

“Our study found a rapid decline in Omicron-specific serum neutralizing antibody titers only a few weeks after the second and third doses of [the Pfizer-BioNTech] BNT162b2,” said the authors of a May 13 study published in JAMA.

BAIT AND SWITCH WITH THE DEPENDENT MEDIA’S HELP: CONFUSE TO DESTROY INFORMED CONSENT. LAST MONTH PFIZER ADMITTED IT WILL NEVER MANUFACTURE THE VACCINE THAT WAS FDA APPROVED. PFIZER QUIETLY SUBMITTED AN UPDATE TO THE CDC, ADMITTING THAT ITS ORIGINALLY LICENSED “COMIRNATY” VACCINE WILL NEVER BE DISTRIBUTED FOR USE. PFIZER HAS EXCLUSIVELY BEEN SUPPLYING ITS VERSION OF THE EXPERIMENTAL VACCINE THAT WAS GRANTED EMERGENCY USE AUTHORIZATION (EUA) BY THE FDA. [MORE]

To further support its claim that Comirnaty is effective in the 12 to 15 age group, Pfizer used an old analysis of 16- to 25-year-olds conducted before the Delta and Omicron surges.

“The efficacy analysis was conducted between November 2020 and May 2021, which was before the Delta and Omicron surges,” and the “only SARS-CoV-2 variant of concern identified from the confirmed COVID-19 cases in this age group was Alpha,” Pfizer said in its press release.

FDA experts question neutralizing antibodies as standard for vaccine effectiveness

During a June 28 meeting of the FDA’s Vaccine and Related Biological Products Advisory Committee (VRBPAC), vaccine experts raised concerns that neutralizing antibodies did not correlate to clinical protection — noting Moderna’s COVID-19 vaccine had a two-fold increase in neutralizing antibody levels compared with Pfizer’s vaccine during clinical trials, but it did not translate into a clinically significant difference in terms of protection against severe disease.

Dr. Ofer Levy, VRBPAC member and infectious disease physician at Boston Children’s Hospital, said during the meeting there is still “no established correlate of protection,” referring to the level of antibodies needed to confer protection.

“You have a lot of data now,” Levy told Pfizer. “What is your relative protection?”

“I would say there is no established correlate of protection,” Kena Swanson, Ph.D., vice president of viral vaccines at Pfizer, told Levy.

Levy said:

“I would like to hear from FDA what their overall approach will be around improving our understanding of correlate protection. We spend a good amount of time reviewing antibody data. We have no doubt antibody data is important. We don’t have a level of antibody that anybody is comfortable stating is correlated [with] protection.

Levy, who said antibodies are important, but T cells are more important, called for federal leadership to establish a “standardization of the T-cell assay and encourage or in fact require the sponsors to gather that information.”

“So what is the effort to standardize the pre-clinical assays?” Levy asked. “This is an effort that’s critical not just now but for future cycles of vaccine revision. If we aren’t able to define a standard for correlate protection we are fighting with one arm behind our back.”

Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research, acknowledged the importance of Levy’s question and said they are “having conversations” with colleagues at the National Institutes of Health and throughout government about how they might move forward, but it is something they “don’t have an answer to yet.”

Marks said as vaccines are developed in the future, it will “become even more important” to define a standard of correlate protection because “we won’t be able to have a large naive population to vaccinate with newer vaccines.”

“We will need to understand the T-cell response better,” Marks said. “I take your point, it’s just that we haven’t solved the problem yet.“

Comirnaty not available in the U.S. 

According to Pfizer’s press release, Comirnaty was previously made available to the 12 to 15 age group in the U.S. under EUA and 9 million U.S. adolescents in this age group have completed a primary series.

“The vaccine, sold under the brand name Comirnaty for adults, has been available under an emergency use authorization since May 2021 for the 12-15 age group,” Reuters reported. “It will now be sold under the same brand name for adolescents as well.”

Yet, Pfizer’s information hotline says it has no specific information on when Comirnaty will be available.

The FDA said Friday the Pfizer-BioNTech vaccine “has been, and will continue to be, authorized for emergency use in this age group since May 2021.”

The CDC’s website states that Comirnaty is “not orderable.”

A branch of the U.S. Department of Health and Human Services overseeing the Strategic National Stockpile indicated Comirnaty was not available because Pfizer did not have time to change the labels.

According to FDA documents, Comirnaty is not available in the U.S. and nobody has received a fully approved and licensed COVID-19 vaccine.

“Comirnaty has not been made available under EUA,” said Dr. Madhava Setty, physician and senior science editor for The Defender.

Setty added:

“The FDA and Pfizer have already stated very quietly, that they have no intent of manufacturing Comirnaty for distribution. Everyone is getting the non-licensed formulation that carries no liability for pharmaceutical companies.”

The CDC website confirms this, stating the Comirnaty formulation “will not be manufactured or made available in the near term even if authorized.”

The FDA on Aug. 23, 2021, approved Pfizer’s biological licensing application (BLA) for its COVID-19 vaccine named Comirnaty for people age 16 and older.

CHD challenged FDA on Comirnaty ‘approval’ for adults

As The Defender reported, there were “several bizarre aspects to the FDA approval” that proved confusing — which led to CHD suing the FDA over its approval of Comirnaty.

The FDA acknowledged that while Pfizer had “insufficient stocks” of the newly licensed Comirnaty vaccine, there was “a significant amount” of the Pfizer-BioNTech COVID vaccine — produced under EUA — still available for use.

The FDA said the Pfizer-BioNTech vaccine under EUA should remain unlicensed but could be used “interchangeably” with the newly licensed Comirnaty product.

The FDA also said the licensed Pfizer Comirnaty vaccine and the existing Pfizer-BioNTech vaccine were “legally distinct,” but proclaimed their differences did not “impact safety or effectiveness.”

Yet, there is a “huge real-world difference” between products approved under EUA compared with those the FDA has fully licensed.

EUA products are experimental under U.S. law and cannot be mandated. A licensed vaccine, such as Comirnaty, can be mandated by employers and schools.

Although Pfizer’s Comirnaty vaccine can be mandated, it has no liability shield. Vials of the branded product, which say “Comirnaty” on the label, are subject to the same product liability laws as other U.S. products.

Only COVID-19 vaccines distributed under EUA — which in the U.S. includes Pfizer-BioNTech, Moderna and Johnson & Johnson — have liability protection under the 2005 Public Readiness and Preparedness Act (PREP).

Under PREP, the only way an injured party can sue a pharmaceutical company for an injury caused by an EUA vaccine is if he or she can prove willful misconduct and if the U.S. government has also brought an enforcement action against the party for willful misconduct. No such lawsuit has ever succeeded.

Comirnaty cannot receive liability protection unless it is fully approved for children and added to the CDC’s immunization schedule bringing it under the auspices of the National Vaccine Injury Compensation Program.

Pfizer-BioNTech and Comirnaty vaccines aren’t interchangeable 

The FDA on Oct. 29, 2021, authorized a manufacturing change to allow an additional formulation of the Pfizer-BioNTech COVID-19 vaccine that uses tromethamine (Tris) buffer instead of phosphate-buffered saline (PBS) used in the originally authorized Pfizer-BioNTech COVID-19 vaccine.

The FDA on Dec. 16, 2021, approved a supplement to the Comirnaty BLA to include a new 30 mcg dose formulation that uses the Tris buffer instead of the PBS buffer used in the originally approved vaccine.

The Pfizer-BioNTech vaccine may contain either the PBS buffer or tris buffer, except for the 5 to 11 age group. The Comirnaty vaccine contains the Tris buffer.

The Pfizer-BioNTech vaccine used for the 5 to 11 age group uses a Tris buffer, despite clinical trialshaving been conducted using Pfizer’s vaccine containing the PBS buffer.

According to Pfizer’s July 8 press release, the FDA relied upon studies conducted prior to the formula change to justify the approval of Pfizer’s Comirnaty vaccine for adolescents ages 12 to 15.

The type of buffer used in a COVID-19 vaccine can affect the potency of the vaccine, how it is stored and the propensity to develop potential adverse events, TrialSite News reported.

​​According to Cleveland Clinic, Tris is commonly used for the prevention and treatment of metabolic acidosis associated with various clinical conditions such as heart bypass surgery or cardiac arrest. It is also used in other vaccines, including Moderna’s COVID-19 vaccine, dengue, smallpox and Ebola vaccines.

The FDA categorizes tromethamine as a category C drug and suggests using tromethamine only if clearly needed.

It is unknown if tromethamine will harm an unborn baby, but animal reproduction studies have shown an adverse effect on the fetus, and there are “no adequate and well-controlled studies in humans.”

“The FDA-evaluated manufacturing data [to] support the change in this inactive ingredient and concluded it did not impact the safety or effectiveness of the product,” Marks, said during an October 2021, press briefing.

According to the FDA’s Letter of Authorization, reissued on Oct. 29, “analytical comparability assessments” revealed the Pfizer-BioNTech COVID vaccine formulations containing Tris and PBS buffers were “analytically comparable.”

Yet, no human or animal trials were conducted to determine the safety or efficacy of the new formula.

“It doesn’t stop infection. Or transmission. Don’t Think of It as a Vaccine.” Twitter Forced to Admit Fault in Suspending Journalist Alex Berenson (and many Others) for Tweeting Truthful Information

From [AFD] Twitter admitted it was wrong to suspend journalist Alex Berenson after the two parties reportedly settled a lawsuit, Berenson shared Wednesday. The social media giant booted Berenson from the platform in August 2021 for contradicting official COVID-19 messaging in a tweet, despite it being factually accurate.  

“It doesn’t stop infection. Or transmission,” Berenson’s offending tweet read. “Don’t think of it as a vaccine. Think of it – at best – as a therapeutic with a limited window of efficacy and terrible side effect profile that must be dosed IN ADVANCE OF ILLNESS. And we want to mandate it? Insanity.” 

None of Berenson’s statement about the vaccine is disputed by Pfizer, the World Health Organization, the Centers for Disease Control and Prevention (CDC) or any other official body, yet it prompted Twitter to suspend the former New York Times journalist in violation of Twitter’s own “five strikes” rule. The tweet was Berenson’s first “strike”.  

After bringing a lawsuit against the social media giant for the violation and “specific commitments” made to him by a Twitter PR executive, Berenson and Twitter engaged in mediation and settlement talks, the details of which the journalist said he is unable to disclose.  

But Berenson’s eye has been on a different prize – a ruling by U.S. District Judge William Alsup entitling Berenson to discovery. The order requires Twitter Inc. to hand over any and all communications regarding Berenson, even “nonparty complaints or inquiries about plaintiff” which include “all texts, emails, voicemails, statements, and other documents pertaining to plaintiff.”  

This means that if any party, whether in the U.S. government, a pharmaceutical company or otherwise contacted Twitter and complained about Berenson, Twitter is obligated to show that. Furthermore, Berenson is allowed to publicize whatever he finds.  

“As we debate the power and political influence of social media companies, this discovery offers a unique opportunity to see how Twitter and the federal government and others may have colluded against my voice,” wrote the journalist in his Substack newsletter. “No one else has this chance. No one. And I am not going to give it up.”  

Berenson added that while he will make some sacrifices, he refuses to concede his rights to discovery.  

“Not for reinstatement, not for money, not for all the viruses in China. I will NOT agree to any settlement that does not preserve my discovery rights about third-party communications AND give me the right to publicize them. There are other things I will (and have) given up, you have to give to get, but this is the reddest of lines.” 

Berenson re-affirmed his pursuit of discovery Wednesday in his newsletter, which he linked to in a tweet. 

“The settlement does not end my investigation into the pressures that the government may have placed on Twitter to suspend my account,” he said. “I will have more to say on that issue in the near future. I made a promise to readers last month, and I take my promises to readers seriously. 

Billionaire Elon Musk, who is currently in the process of acquiring Twitter, replied to Berenson’s tweet, apparently having read Berenson’s article: 

“Can you say more about this: ‘… pressures that the government may have placed on Twitter …’ 

Media Destroyed Informed Consent: The Only FDA Approved "Vaccine" is Comirnaty. It’s not Available in US. All Other Shots are Emergency Use, which are Legally Distinct, Not Interchangeable w/Comirnaty

The following is from an amicus brief filed by Defending The Republic (DTR) in the case of NFIB v. OSHA that was before the US Supreme Court. [MORE] The footnotes and complete brief can be found here. It was filed in December 2021.

DTR is a non-profit organization that is dedicated to defending the Constitution, the rule of law, and protecting individual rights of Americans including medical freedom and religious liberty. DTR represents over thirty military service members in litigation involving the violation of their religious freedoms and their other constitutional and statutory rights to refuse mandatory vaccination with experimental COVID-19 treatments.

SUMMARY

A critical issue that has not been addressed in the Applicants' briefs, the OSHA Mandate, or the opinions by the Fifth or Sixth Circuit Courts of Appeals, is that OSHA and other federal agencies are mandating the administration of an experimental product that has not been approved by the FDA.4 In fact, none of the approved "vaccine" is available in the United States.

DTR urges the Court to grant Applicants' request to find that the OSHA Mandate exceeds the agency's authority. But first, it is imperative to explain why the OSHA Mandate is properly understood as an experimental vaccine mandate. Currently, the only COVID-19 "vaccine''5 that has been approved by the FDA is Pfizer-BioNTech's Comirnaty, which is not available in the United States. The only COVID-19 products that are available are not FDA approved and instead are subject to an EUA.

As explained below, the distinction between an EUA and an FDA-approved product matters. See infra Section III. In particular, the FDA's grant of EUA requires little, if any, demonstration that the EUA product is safe and effective. Nor does the EUA include FDA review or approval of manufacturing processes, facilities, storage, distribution, or quality control procedures. This is why the FDA has acknowledged the products are "legally distinct.''6

The unavailability of Comirnaty raises a second question that also has not been asked, much less addressed, by OSHA or in the judicial decisions under review. Federal laws and applicable FDA regulations expressly provide a "right to refuse" experimental or EUA products. See 21 U.S.C. § 360bbb- 3(e)(1)(A)(ii)(III). Yet, the OSHA Mandate unlawfully overrides or circumvents those laws.

These rights to informed consent and to refuse experimental drugs--embodied not only in federal law, like 21 U.S.C. § 360bbb-3, but also international law and conventions like the Nuremburg Code--should foreclose such a wide-ranging mandate. DTR urges this Court to consider the enormous wrongful consequences of imposing an illegal mandate requiring nearly the entire United States adult workforce to take an experimental and irreversible medical treatment.

The immeasurable ramifications of endorsing a near-universal federal mandate justify granting a stay to give more time for deeper consideration by this Court, the political branches, public health experts, and the citizens of the United States to consider the legal arguments and scientific evidence on the safety and efficacy of the newly manufactured "vaccines," the rapidly proliferating range of therapies, and alternative federal, state, and local public health measures. Surely a stay to allow this Court to hear the arguments presented by all Parties and Amici is appropriate given the momentous consequences for tens of millions of Americans who face the loss of their rights to work, education, travel, worship and other fundamental constitutional rights unless they submit to an unproven, experimental medical treatment with an unprecendented history of adverse effects including deaths.

The Development of COVID-19 Vaccines

The pharmaceutical industry undoubtedly moved quickly to develop vaccines in response to the COVID- 19 pandemic. This was done in conjunction with the United States government's Operation Warp Speed, that awarded billions to these companies to spur the development and distribution of the vaccines.7 To clear the way for expedited development, the Secretary of Health and Human Services ("HHS") issued notice, pursuant to section 564 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3, that COVID-19 had a "significant potential to affect national security or the health and security of United States Citizens" and that "circumstances exist justifying the authorization of emergency use of drugs and biological products during the COVID-19 pandemic." 85 Fed. Reg. 18,250 (April 1, 2020).

The currently available COVID-19 "vaccines" are the results of these efforts. The Pfizer-BioNTech vaccine received its EUA on December 11,2021.s This was followed by EUAs for the Moderna and Johnson and Johnson Vaccines ('WIoderna Vaccine" and "Janssen Vaccine") on December 18, 2021 and February 27, 2021, respectively) These EUAs were granted after limited testing. For example, the Pfizer- BioNTech Vaccine's EUA was issued based on an "entire enrolled study population [that] had a median follow-up of less than 2 months.''10 Typically, vaccines "require years of research and testing before reaching the clinic.''11

II. The FDA-Approved Comirnaty is Unavailable to the American Public

On August 23, 2021, the FDA approved the Pfizer- BioNTech mRNA vaccine under the marketed name Comirnaty.12 Soon thereafter, on September 9, 2021, President Biden announced that he would "protect vaccinated workers from unvaccinated co-workers" by having the Department of Labor issue "an emergency rule to require all employers with 100 or more employees . . . to ensure their workforces are fully vaccinated or show a negative test at least once a week."13

With these marching orders, the Secretary of Labor, through OSHA, issued the OSHA ETS, which mandated that private businesses with 100 or more employees "develop, implement, and enforce a mandatory COVID-19 vaccination policy, with an exception for employers that instead adopt a policy requiring employees to either get vaccinated or elect to undergo regular COVID-19 testing and wear a face covering at work in lieu of vaccination." OSHA ETS, 86 Fed. Reg. at 61,402. Americans subject to this ETS are in compliance if they receive the recommended minimum doses of COVID-19 vaccines that are "[a]pproved or authorized for emergency use by the FDA." Id. at 61,479.

Notwithstanding the jurisdictional issues underlying the OSHA Mandate, there is a significant problem concerning how Americans are forced to comply with the mandate. Specifically, the only FDA- approved vaccine - Comirnaty - is not available to the American public. According to the CDC, "COMIRNATY products are not orderable at this time.''14 As of December 16, 2021, "there is not sufficient approved vaccine [i.e., Comirnaty] available for the population for whom it is authorized." See supra, FDA Pfizer-BioNTech Expansion Letter, note 6 at 5 n.9. In fact, it appears that Comirnaty is not available at all in the United States. Pfizer and the National Institutes of Health confirmed that Comirnaty would be unavailable for months after its approval. 15

The Department of Justice ("DOJ") finally conceded the unavailability of Comirnaty through defense counsel for DOD in Austin, where DTR represents service members challenging the DOD Mandate. While DOD initially claimed that the DOD in fact possessed Comirnaty and was administering it to service members, in oral argument, DOJ defense counsel acknowledged that not only did it not have Comirnaty and did not know when it would it get it, but also "could not say even whether vaccines labeled 'Comirnaty' exist at all." Doe v. Austin, 2021 WL 5816632, at *5 (N.D. Fla. Nov. 12, 2021) (citations omitted).16

DOD is the largest purchasing organization in the United States, and given its priority for national security matters, it would necessarily go to the front of the line for any purchasing COVID-19 vaccines. Yet DOD does not have Comirnaty and to this day the DOD cannot say when it will get Comirnaty. If the DOD cannot obtain Comirnaty, then how can average Americans who are subject to the OSHA Mandate? And perhaps more importantly, how can employees be fired for the failure of their employers to obtain a vaccine that even the DOD cannot procure?

The unavailability of Comirnaty is important. First, while OSHA purports to give employers the option of requiring vaccination or allowing testing and masks, it does not hide its real intent to force employees to choose vaccination to keep their jobs. If an employee opts out of their employer's mandatory vaccination policy, OSHA believes its ETS and the costs it imposes on that employee - which includes paying for regular testing - "creates a financial incentive for those employees to become fully vaccinated and avoid that cost." OSHA Mandate, 86 Fed. Reg. at 61,532.

As Judge Larsen observed in his dissenting opinion on the emergency motion to dissolve the stay of the OSHA Mandate, the Mandate's main purpose is to compel vaccination:

Here, employers, not employees, control any non-vaccine option in the first instance; and OSHA has been candid that it has stacked the deck in favor of vaccination ... OSHA has alerted us to no prior attempt on its part to mandate a solution that extends beyond the workplace walls-- much less a permanent and physically intrusive one, promulgated on an emergency basis, without any chance for public participation. But that it is what OSHA has done here. A vaccine may not be taken off when the workday ends; and its effects, unlike this rule, will not expire in six months.17

Second, and in consideration of OSHA's coercive policy, workers will only be able to comply with the OSHA Mandate if they receive a vaccine under an EUA.is This is especially important because EUA vaccines bypass the FDA and PHS Act's requirements for safety and efficacy.

BAIT AND SWITCH WITH THE DEPENDENT MEDIA’S HELP: CONFUSE TO DESTROY INFORMED CONSENT. Last month Pfizer Admitted it Will NEVER Manufacture the Vaccine that was FDA Approved. Pfizer quietly submitted an update to the CDC, admitting that its originally licensed “Comirnaty” vaccine will never be distributed for use. Pfizer has exclusively been supplying its version of the experimental vaccine that was granted Emergency Use Authorization (EUA) by the FDA. From the Pfizer update, via independent journalist Jordan Schachtel:

“Pfizer received initial FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). At that time, the FDA published a BLA package insert that included the approved new COVID-19 vaccine tradename COMIRNATY and listed 2 new NDCs (0069-1000-03, 0069-1000-02) and images of labels with the new tradename. These NDCs will not be manufacturedOnly NDCs for the subsequently BLA approved tris-sucrose formulation will be produced.” [MORE]

III. Important Differences Between EUA and FDA-Approved Vaccines

There are significant differences between the FDA's approval standards and the EUA standards. EUA vaccines require little to no proof of safety or efficacy. FDA vaccine approvals do.

The FDA may grant an EUA where: (1) the HHS Secretary has declared a public health emergency that justifies the use of an EUA, see 21 U.S.C. § 360bbb- 3(b)(1); and (2) the FDA finds that "there is no adequate, approved, and available alternative to the product for diagnosing, preventing, or treating" the disease in question. 21 U.S.C. § 360bbb-3(c)(3).

The differences between licensed vaccines and those subject to an EUA render them "legally distinct." See supra, FDA Pfizer-BioNTech EUA Expansion Letter, note 6 at 2 n.8. First, the requirements for efficacy are much lower for EUA products than for licensed products. EUAs require only a showing that, based on scientific evidence "if available," "it is reasonable to believe," the product "may be effective" in treating or preventing the disease. 21 U.S.C. §360bbb-3(c)(2)(A).

By plan, those vaccines that are subject to the OSHA Mandate have relatively little data to support their authorization. The Pfizer-BioNTech Vaccine was granted its EUA after approximately 2 months of follow-up testing. See supra, FDA Pfizer-BioNTech EUA Review Memo, note 10 at 17. The Moderna Vaccine received its EUA after providing its studies to the FDA "with a median of 7 weeks of follow-up after the second dose.''19 And for the Janssen Vaccine, which also received an EUA, "the median follow-up duration for participants in the efficacy and safety analysis populations was 8 weeks after vaccination.''20

Second, the safety requirements are minimal, requiring only that the FDA conclude that the "known and potential benefits ... outweigh the known and potential risks" of the product, considering the risks of the disease. 21 U.S.C. §360bbb-3(c)(2)(B). There is no requirement that the FDA know the potential risks of the product.

In comparison, vaccines that go through traditional FDA review typically take 10 years or more to reach approval.21 And the approval process compiles more information on the risks of the vaccine, gathered through lab testing and clinical trials, "to assess the safety and effectiveness of each vaccine.''22

A. The Right to Refuse an EUA Vaccine

The FDA's grant of an EUA is subject to informed consent requirements to "ensure that individuals to whom the product is administered are informed" that they have "the option to accept or refuse administration of the product." 21 U.S.C. § 360bbb- 3(e)(1)(A)(ii)(III).

For the three COVID-19 vaccines, FDA implemented the "option to accept or refuse" condition described in Section 564(e)(1)(A)(ii)(III) in each letter granting the EUA by requiring that FDA's "Fact Sheet for Recipients and Caregivers" be made available to every potential vaccine recipient. These include the statement that the recipient "has the option to accept or refuse" the vaccine.23 Moreover, the EUA label itself must expressly state that the recipient has a "right to refuse" administration of the EUA product. Accordingly, the OSHA Mandate contradicts established federal law and will require any covered employer, including state agencies, to violate an express requirement of federal law and the express terms of the FDA labeling and packaging requirements.

B . OSHA Cannot Override Informed Consent Rights

The norm of informed consent has been "firmly embedded" in U.S. law and FDA regulations for nearly 60 years. Adullahi v. Pfizer, Inc., 562 F.3d 163, 182 (2d Cir. 2009). Congress first enacted this requirement in 1962 drawing on the Nuremberg Code and the Helsinki Declaration, "which suggests the government conceived of these sources' articulation of the norm as a binding legal obligation." Adullahi, 562 F.3d at 182. Informed consent requirements are a cornerstone of FDA rules governing human medical experimentation. See, e.g., 21 C.F.R. §§ 50.20, 50.23-.25, 50.27, 312.20, 312.120 (2008); 45 C.F.R. §§ 46.111, 46.116-117.

In any case, OSHA has not even acknowledged workers' informed consent rights, much less explained how its mandate can override these rights or force private and public sector employers into violating these rights. Accordingly, the OSHA Mandate cannot stand.

A helpful analogy when considering forced vaccination is to compare the present case to the DaD's much narrower Anthrax Vaccination Immunization Program. Courts enjoined that program, as it sought to impose a vaccine mandate on service members using experimental, unapproved anthrax mandates, which were expressly barred by statute. See 10 U.S.C. §§ 1107 and 1107a. Even in those cases, courts recognized the limitations of DaD power over military service members, observing "the United States cannot demand that members of the armed forces also serve as guinea pigs for experimental drugs." Doe No. 1 v. Rumsfeld, 297 F.Supp.2d 119, 135 (D.D.C. 2003) (granting injunctive relief against DaD for mandating an EUA anthrax vaccine).24 Certainly, aSHA has even less authority over American workers.

IV. EUA and FDA Licensed Products do not have the "Same Formulation" and are not "Interchangeable"

Notwithstanding any potential assertions to the contrary, the EUA and licensed versions of Pfizer- BioNTech do not have the "same formulation" as revealed by a simple inspection of the Pfizer Vaccine EUA letters and the Summary Basis for Regulatory Action (SBRA) for Comirnaty. Thus, they cannot be treated as "interchangeable," because there is no legal basis to administer an EUA product as if it were the FDA-licensed product. By definition, they are different.

There is no evidence in the public record for finding that the EUA Pfizer-BioNTech vaccine and FDA-licensed Comirnaty have the "same formulation." There is, however, ample evidence for finding that they do not. The most detailed information on Comirnaty's composition, manufacturing process, manufacturing locations and other matters approved by the FDA is included in the FDA Comirnaty SBRA, nearly all of which is redacted,25 while most of this information was never made available in the Pfizer- BioNTech EUA applications or authorizations. To the extent such information is available, it reveals differences in the composition of the EUA and the licensed product.26 There is also no dispute that the FDA EUA does not address manufacturing processes or locations, which are addressed in the Comirnaty license. See August 23 Comirnaty SBRA at 12-13.

For the same reasons, the public record does not support any argument that the two admittedly "legally distinct" products are "interchangeable." "Interchangeable" and "interchangeability" are specifically defined terms in Section 351 of the Public

Health Service Act ("PHS Act"), 42 U.S.C. § 262, in relation to a "reference product," which is a biological product licensed under Section 351(a) of the PHS Act, 42 U.S.C. § 262(a). For the purposes of determining "interchangeability," the "reference product" must be an FDA-licensed product; in this case, the FDA- licensed Comirnaty Vaccine. But the "interchangeable" product, the EUA BioNTech Vaccine, must be the subject of a later filed "abbreviated" application under 42 U.S.C. § 262(k), and there is no indication that any such application was ever filed by BioNTech, much less reviewed or approved by the FDA.

Any "interchangeability" determination would therefore reverse the temporal order of the COVID-19 licensed product and the interchangeable product. The reference product under 42 U.S.C. § 262(a) is the first licensed product, and therefore the basis for determining the interchangeability of the later product (i.e., the generic or EUA product). Here, however, the EUA Pfizer-BioNTech Vaccine is the earlier product, while the licensed Comirnaty is the latter product; the earlier EUA product cannot rely on the FDA's safety and efficacy determinations for Comirnaty. Thus, an "interchangeability" determination would be a transparent attempt to retroactively license the earlier EUA Pfizer-BioNTech Vaccine, solely for the purpose of enabling the unlawful vaccine mandate.

Moreover, "FDA licensure does not retroactively apply to vials shipped before [FDA] approval." Austin, 2021 WL 5816632, at *6. Any EUA-labeled vaccines manufactured before licensure and "vaccines produced after August 23 in unapproved facilities--remain 'product[s] authorized for emergency use,"' i.e., EUA rather than licensed products. Id. In any case, such a post hoc interchangeability determination should not even be considered by the Court. "An agency must defend its actions based on the reasons it gave when it acted." DHS v. Regents of the Univ. of Cal., 140 S.Ct. 1891, 1909 (2020).

CONCLUSION

This Court should stay the OSHA Mandate because the unavailability of Comirnaty precludes compliance. Congress has not clearly granted the agency the power to require private employers to mandate that their employees take an experimental vaccine.27 Congress has not granted OSHA the authority to require State agencies to impose and police a mandate which cannot be satisfied through distribution of FDA-approved vaccines. No American can be compelled to suffer an injection of an experimental product.

Heart Disease in Children Explodes Since the Vaccine

From [MERCOLA] Heart conditions in children who don’t normally get heart disease are being reported since they started getting the COVID jabs, and The Irish Light is bringing light to the topic by criticizing mainstream media for its silence on the topic.

To ignore this and continue onward with the shot program is “the greatest crime ever committed by an Irish government,” the newsletter says, but “as hard as the HSE tries to cover up the horrifying impact of the COVID vaccine on Irish children, there is no containing the staggering toll of sudden deaths in young people.”

A sudden rise in hepatitis cases is suspicious, too, the newsletter says: “Why are so many healthy children dying? What has changed in their lives to cause it? We all know the answer but many still do not have the courage to say it out loud because they too may meet the same fate.”

While it’s being ignored right now, it won’t be forever, the newsletter suggests, because “soon the dam of silence will burst because the injury levels are too alarming to ignore.”

Documentary, "The Viral Delusion." The Tragic Pseudoscience of SARS-CoV-2 & The Madness of Modern Virology (1-5)

From [HERE] The Untold Story Behind The Pandemic

The doctors, scientists and journalists featured in THE VIRAL DELUSION examine in detail the scientific papers that were used to justify the pandemic, and what they find is shattering. In this shocking, five-part, seven-hour documentary series, they explore every single major claim, from the “isolation” of the virus to its so-called genetic sequencing, from the discovery of how to “test” for SARS-CoV2 to the emergence of “variants” that in reality, they explain, exist only on a computer. Their point: is that the so-called SARS-CoV-2 virus exists only as a mental construct whose existence in the real world has been disproven by the science itself.

They then go back through history to reveal how the birth and growth of virology has led to massive misunderstanding and misdiagnosis of disease: from Smallpox to the Spanish Flu, Polio to AIDS, to COVID itself – putting the pandemic in a whole new context better understood not as settled science, but the tragic culmination of misunderstood biology by the growing cult of virology, built on pseudo-science, to which much of the rest of the medical profession defers without understanding or examination, and the tragic consequences that have been wrought in its name.

In 2019, the virologists took centre stage, and for the first time on film, their methods, miscues and tragedy they have wrought are put under the spotlight, revealing the extraordinary leaps of fantasy buried in their methodology, the contradictions quietly acknowledged in their papers, their desperate effort to change the language to justify their findings, the obvious incongruence of their conclusions and the extraordinary stakes for our entire society in whether we continue to blindly follow their lead into a full-scale war against nature itself.

Featuring: Andrew Kaufman, MD; Tom Cowan, MD; Stefan Lanka, Virologist; Torsten Engelbrecht, journalist; Claus Kohnlein, MD; Kevin Corbett, PhD RN; David Rasnick, Biochemist PhD; Mark Bailey, MD; Dawn Lester and David Parker, Authors; Stefano Scoglio, Biochemist PhD; Saeed Qureeshi, Chemist PhD; Celia Farber, Journalist; Harold Wallach, PhD; Pam Popper, PhD, ND; Charles Geshekter, PhD; Amandha Vollmer ND, Jim West, Author; Larry Palevsky MD; and more.

The opening episode, which is two hours and twenty minutes, will be available for free from March 21st until May 21st.

Government of Alberta Says the Leading Cause of Death in 2021 was ‘Unknown Causes’ and Reported a Surge in Deaths. Nearly All the Top Causes of Death Also are the Top Adverse Reactions to COVID Shots

From [HERE] Recent data on the leading causes of death in Alberta show a spike in the 2021 mortality rate due to “ill-defined and unknown causes.”

The data, published on June 30 by Service Alberta, ranks the 30 most common causes of death in the province last year.

For the first time in the past twenty years, the category of “ill-defined and unknown causes of mortality” was the number one cause of death in 2021, resulting in a total 3,362 deaths, up from 1,464 in 2020, and 522 the year before that.

The unknown cause of death category emerged on the list in 2019, previously it had not been included in the ranking list dating back to 2001.

Dr. Daniel Gregson, an associate professor specializing in infectious diseases and microbiology at the University of Calgary, told CTV News that the reasons behind the emergence of the unknown causes of death category last year are “probably multifactorial.”

He said those factors may include a lack of medical resources to determine the cause of death, delayed access to healthcare services, and post-COVID complications.

Identified cases of COVID-19 are ranked as the third leading cause of death in Alberta in 2021 with 1,950 deaths—a jump from 1,084 in 2020 when the pandemic began.

From 2015 to 2020, organic dementia was listed as the leading cause of death in Alberta with chronic ischemic heart disease the dominant cause from 2001 to 2014.

In 2021, organic dementia came in second, contributing to 2,135 deaths, while chronic ischemic heart disease ranked fourth with 1,939.

Among the other top causes of death listed were: malignant neoplasms of trachea, bronchus and lung (1,552), acute myocardial infarction (1,075), chronic obstructive pulmonary disease (1,028), diabetes mellitus (728), stroke (612), and accidental poisoning by and exposure to drugs and other substances (604). [MORE]

2022 Genesis Prize was Awarded to Pfizer CEO Albert Bourla for His Effort to Create Human Dependency on Deadly "Vaccines" which cause the Undetected, Slow Motion Extermination of Undesired Populations

From [HERE] The Genesis Foundation announced in January that the winner of its annual prize for 2022 was Albert Bourla, CEO of Pfizer, which produced a COVID-19 vaccine that has been used by Israel and other countries around the world to inoculate their populations against the coronavirus.

The Genesis Prize honors individuals who serve as an inspiration to the next generation of Jews through their outstanding professional achievement and commitment to Jewish values and the Jewish people.

Bourla received the highest number of votes in a recent global vote in which more than 200,000 people from 71 countries participated. His nomination as prize laureate was then unanimously approved by the Genesis Foundation selection committee, the foundation said in a statement.

The committee commended Bourla “for his leadership, determination, and especially for his willingness to assume great risks.”

“Unlike CEOs of most other major companies working on developing COVID-19 vaccines, Dr. Bourla declined billions of dollars in US federal subsidies in order to avoid government bureaucracy and expedite development and production of the vaccine,” the statement said. “As a result, Pfizer’s COVID-19 vaccine was ready in record time: months instead of years.”

The foundation also noted “Dr. Bourla’s pride in his Jewish identity and heritage, his commitment to Jewish values and his support for the State of Israel.”

President Isaac Herzog will present Bourla with the $1 million prize at a ceremony in Israel to be held on June 29.

An Israeli health worker administers a dose of the Pfizer-BioNTech COVID-19 vaccine to a child at the Clalit Health Services in the central Israeli city of Modiin on January 2, 2022. (Photo by GIL COHEN-MAGEN / AFP)

Winners customarily donate the prize to a philanthropic cause and Bourla has asked that the money go toward preserving the memory of the victims of the Holocaust, “with a particular emphasis on the tragedy suffered by the Greek Jewish community,” the statement said.

Born in Thessaloniki, Greece, Bourla grew up as the child of Holocaust survivors.

“I did not set out to live a public life, and I never could have imagined that I might one day receive the profound honor of the Genesis Prize and stand alongside my extraordinary fellow nominees,” Bourla was quoted as saying in the statement. “I accept it humbly and on behalf of all my Pfizer colleagues who answered the urgent call of history these past two years and together bent the arc of our common destiny.”

“I was brought up in a Jewish family who believed that each of us is only as strong as the bonds of our community; and that we are all called upon by God to repair the world,” Bourla said, referring to a central tenet in Judaism of perfecting the world. “I look forward to being in Jerusalem to accept this honor in person, which symbolizes the triumph of science and a great hope for our future.”

The prize is usually awarded in Jerusalem each June at a dinner attended by the prime minister. But the ceremony has been called off the past two years due to the pandemic.

Genesis Foundation CEO Stan Polovets praised Bourla, saying he “personifies two of the most fundamental Jewish values: the commitment to the sanctity of life and to repairing the world.”

“Millions of people are alive and healthy because of what Dr. Bourla and his team at Pfizer have accomplished,” Polovets said, adding that it was a “proud moment not just for the winner but for the entire Jewish community.

“A people so small in number are having such an outsized impact on this global effort to save lives,” Polovets said.

Other candidates on a short list to win the prize, often referred to as the “Jewish Noble,” were actor, producer, director and activist Sacha Baron Cohen; fashion designer Diane von Furstenberg; philosopher and author Yuval Noah Harari; actress and activist Scarlett Johansson; and human rights activist and Nazi-hunter Serge Klarsfeld.

Previous winners of the Genesis Prize include artist Anish Kapoor, violinist Itzhak Perlman, former New York City mayor Michael Bloomberg and actor-director Michael Douglas. In 2018, US Supreme Court Justice Ruth Bader Ginsburg received a lifetime achievement award from the foundation. [MORE]

Official Government Reports, Confidential Pfizer Documents & the Cost of Living Crisis Prove Your Government is Trying to Kill you and Depopulate the Planet

From [EXPOSE] In 1993 a book was published by a former spy of the MI6 named Dr John Coleman. In that book, Dr Coleman wrote the following – 

“At least 4 billion “useless eaters” shall be eliminated by the year 2050 by means of limited wars, organized epidemics of fatal rapid-acting diseases and starvation. Energy, food and water shall be kept at subsistence levels for the non-elite, starting with the White populations of Western Europe and North America and then spreading to other races. 

The population of Canada, Western Europe and the United States will be decimated more rapidly than on other continents, until the world’s population reaches a manageable level of 1 billion, of which 500 million will consist of Chinese and Japanese races, selected because they are people who have been regimented for centuries and who are accustomed to obeying authority without question.”

Many people would most likely disregard the above claims as “tinfoil hat nonsense”. 

But unfortunately, official Government data, confidential Pfizer documents, and real-world events such as the current cost of living crisis, the alleged impending climate change disaster, the Covid-19 pandemic, and the ongoing development of Artificial Intelligence, strongly suggest that there exists an agenda to depopulate the world, and your Government is, in essence, attempting to kill you.

We are now living in a world where Governments and Institiutions are telling us we are in a race to to prevent a “disastrous” increase in global temperatures due to greenhouse gas emissions. 

The vast majority of those greenhouse gas emissions are Carbon dioxide (CO2). A gas that every single human being on the planet produces every single time they exhale. 

In one day, the average person breathes out around 500 litres of the greenhouse gas CO2 – which amounts to around 1kg in mass. 

This doesn’t sound much until you take into account the fact that the world’s population is around 6.8 billion, collectively breathing out around 2500 million tonnes of the stuff each year – which is around 7% of the annual CO2 tonnage churned out by the burning of fossil fuel around the world.

Therefore, if we’re to believe the tightly controlled and censored narrative around climate change, human beings are one of the biggest contributors to it by simply just being alive. 

So, therefore, if the “elite” wanted to save the planet, a good start would be to reduce the world’s population which would, in turn, reduce the carbon dioxide produced naturally by humans breathing, and reduce the amount of fossil fuels required to sustain a person’s quality of life. 

But what if we’re being lied to about the impending climate change doom that now litters every News channel? Why would the so-called “elite” be so eager to reduce the world’s population then?

Well, we only need to look to the advancement of technology and Artificial Intelligence to realise that humans aren’t really needed as much as they used to be in order to keep the rich, rich. And pretty soon they may no longer be needed at all. 

If you can’t see that you pretty much living in a slave system designed to keep the rich, rich and the poor, poor, then you’ve been living your life with your head in the sand. 

Nobody ever gets rich working 9 to 5, but millions are trained to believe that this is what you should aim to do when you grow up. Granted, you can start your own business and have others slave away for you, but even then the “taxman” comes to make sure you have to keep up the endless routine of sleep, work, repeat for another year. Or if you’re extremely successful one of the large corporations will come knocking to buy you out. 

The system is rigged.

Another example is how no matter how much your earnings increase throughout the years, your outgoings will remain relative to or surpass that increase. 

Take the cost of a house for example. For most people, the mortgage or rent alone will take a huge chunk of their wages, and it’s a cost that rises by the year. Is it because houses actually cost that much? Or is it because the system’s designed to ensure that most will never be able to break free from the life of slavery they have been indoctrinated to accept?

For centuries the “elite” have needed you to accept and remain trapped in the system to essentially make them rich. But now they don’t need you, because they have developed technology, robotics and Artificial Intelligence that can do the job for them, and this technology is now more advanced than most people realise. 

One day soon there will be no jobs for millions of people. In effect rendering millions to be known as “useless eaters”. 

This means the world is at a crossroads, and the elite has two choices. They sustain millions or even billions of people with financial support and help to ensure they survive and live quality lives. Or, they set about to depopulate the world.

Unfortunately, evidence suggests they chose the depopulation route a while ago, and their plan to do so is already in motion. 

Here are just a few of the things the “elite” have done and are doing in order to depopulate the world. 

The COVID-19 Pandemic: Killing the Elderly & Vulnerable

In March 2020 the British people were told that they must “stay at home” in order to “protect the NHS” and “save lives”. They were also told that the authorities needed just “three weeks to flatten the curve”. This was allegedly because of the threat of a new and emerging virus which we’re told originated in the city of Wuhan, China.

But evidence suggests the Covid-19 pandemic was in fact an exaggerated lie. A lie that involved prematurely ending the lives of thousands upon thousands of people, who you were told died of Covid-19. A lie that has involved committing one of the greatest crimes against humanity in living memory. A lie that has required three things – fear, your compliance, and a drug known as Midazolam.

Serious illness in Covid-19 allegedly presents pneumonia and accompanying respiratory insufficiency. Therefore typical symptoms include breathlessness, cough, weakness and fever. We’re also told that people who suffer deteriorating respiratory failure and who do not receive intensive care, develop acute respiratory distress syndrome with severe breathlessness.

While midazolam (think diazepam on steroids) can cause serious or life-threatening breathing problems such as shallow, slowed, or temporarily stopped breathing that may lead to permanent brain injury or death.

UK regulators state that you should only receive midazolam in a hospital or doctor’s office that has the equipment that is needed to monitor your heart and lungs and to provide life-saving medical treatment quickly if your breathing slows or stops.

Knowing that would you use midazolam to treat people who were suffering pneumonia and respiratory insufficiency allegedly due to Covid-19?

Because that’s precisely what they did in the UK, and they administered it by the truckload in care homes. 

In March 2020, the UK Department of Health & Social Care purchased a two-year supply of midazolam and was looking to purchase more (source). And they certainly made use of it.

According to official data in April 2019 up to 21,977 prescriptions for Midazolam were issued, containing 171,952 items, the vast majority being Midazolam Hydrochloride. However in April 2020 45,033 prescriptions for Midazolam were issued, containing 333,229 items, the vast majority being Midazolam Hydrochloride. 

That is a 104.91% increase in the number of prescriptions issued for Midazolam and a 93.85% increase in the number of items they contained. 

But these weren’t issued in hospitals, they were issued by GP practices. This means they were administered to the elderly and vulnerable who had been released from hospital under the instruction of then Health Secretary Matt Hancock and into understaffed and overwhelmed care homes. 

According to the UK’s Office for National Statistics, three in every five Covid-19 deaths occurred in those who suffered learning difficulties and disabilities (see here).

Do you really believe there’s a virus so clever that it knows to only kill people who are disabled or have learning difficulties?

In relation to deaths of people with learning difficulties the ONS said – ‘the largest effect was associated with living in a care home or other communal establishment.

Having a learning difficulty and being in care doesn’t mean you are more likely to die of Covid-19. What it means is that you are much more likely to have a DNR order placed on you without informing yourself or your family, which Carers / NHS staff then use as permission to put you on end-of-life care, which involves the administration of Midazolam.

The evidence for this is vast, and you can read a full investigation exposing the Midazolam scandal in the UK here

Covid-19 Vaccination: Infertility & Genocide

Covid-19 vaccination is going to lead mass depopulation on top of the thousands it has already killed. 

The latest reports released by medicine regulators around the world reveal that there have been at least 7.3 million injuries reported as adverse reactions to the Covid-19 injections up to late May and early June 2022, including 77,068 deaths (source).

However, these horrific figures do not illustrate the true nature of the consequences of Covid-19 vaccination because it is estimated by medicine regulators that just 1 to 10% of adverse events are actually reported.

But something much more sinister is occurring with these experimental injections, and the evidence can all be found in both official Government data and the confidential documents the U.S. Food & Drug Administration (FDA) attempted to delay publishing by 75 years but has been forced to publish by court order. 

In early January 2022, Federal Judge Mark Pittman ordered the FDA to release 55,000 pages per month. They released 12,000 pages by the end of January.

Since then, PHMPT has posted all of the documents on its website. The latest drop happened on 1stJune 2022.

One of the documents contained in the data dump is ‘reissue_5.3.6 postmarketing experience.pdf’. Page 12 of the confidential document contains data on the use of the Pfizer Covid-19 injection in pregnancy and lactation.

Confidential Pfizer Documents reveal 90% of Covid Vaccinated Pregnant Women lost their Baby

Pfizer state in the document that by 28th February 2021 there were 270 known cases of exposure to the mRNA injection during pregnancy.

Forty-six percent of the mothers (124) exposed to the Pfizer Covid-19 injection suffered an adverse reaction.

Of those 124 mothers suffering an adverse reaction, 49 were considered non-serious adverse reactions, whereas 75 were considered serious. This means 58% of the mothers who reported suffering adverse reactions suffered a serious adverse event ranging from uterine contraction to foetal death.

There were 34 outcomes altogether at the time of the report, but 5 of them were still pending. Pfizer note that only 1 of the 29 known outcomes were normal, whilst 28 of the 29 outcomes resulted in the loss/death of the baby. This equates to 97% of all known outcomes of Covid-19 vaccination during pregnancy resulting in the loss of the child.

When we include the 5 cases where the outcome was still pending it equates to 82% of all outcomes of Covid-19 vaccination during pregnancy resulting in the loss of the child. This equates to an average of around 90% between the 82% and 97% figure.[MORE]

Puppetician Biden Pledges $9B More to Pfizer for COVID Shots. All Doses Continue to be Distributed as Emergency Use (Not FDA Approved) Enabling Legal Immunity for Any Injury Caused by the Injections

The federal government has given complete immunity to Pfizer, Moderna, and J&J for any injury caused by their Covid-19 vaccines.  That’s right: you cannot sue them if you are injured by their Covid-19 vaccine.  (See Note 1 to read the law yourself.)  So, while their product may not give you immunity, Pfizer and Moderna are guaranteed immunity.  Said immunity also shields doctors, hospitals and any other persons who administer or coerce people to take deadly COVID injections.

And it gets even worse.  These companies are even immune for – hold your breath – willful misconduct.  That may sound crazy, but it is shockingly true.  You can only sue them for willful misconduct if the federal government first sues them for such conduct.  (See Note 2 below to read the law yourself.)  And what are the odds the federal government will do so after wildly promoting the vaccine?  About as likely as the FDA ever admitting they promoted a vaccine that caused widespread harm. [MORE]

From [HERE] Is there any more doubt that the COVID-19 plandemic, which was used to transfer America’s wealth to Big Pharma with literally TRILLIONS of taxpayer funds transferred into their accounts, has now allowed Pfizer to have complete control of the country by buying the White House and President of the United States?

It began with fellow billionaire Donald Trump, of course, in 2020 who strong-armed the FDA into giving fast-track emergency use authorization to Pfizer’s COVID-19 vaccine.

Then Biden was installed as President and kept the coffers full, and now that 80% of Americans have already received a COVID-19 vaccine and demand is waning, with 98 million doses of Pfizer’s vaccine currently sitting unused due to lack of demand, the call was put in to Joe this week to keep the faucet running, and the White House obliged and pledged another $9 BILLION for 300 million more doses of the deadly COVID-19 shots.

Trump and Biden might disagree on a lot of things, but Pfizer COVID-19 vaccines ain’t one of them. (Bitchute channel.)

The top three firms who hold the most stock in Pfizer are Vanguard, Blackrock, and State Street (source), and there probably are very few investment firms who do NOT own some Pfizer stock, so when you see officials with the FDA, CDC, and others promoting Pfizer COVID-19 vaccines, they are probably all shareholders and cashing in, as are most members of Congress (unfortunately, these records at opensecrets.org only go through 2018; it would be interesting to see from 2020 and later.)

Pfizer is already swimming in record profits, but that hasn’t stopped the drug company from gouging the American taxpayer for every last dollar.

On Wednesday, the Biden Administration signed off on a new vaccine supply deal with Pfizer for $3.2 billion for 105 million COVID injections, but that’s only for the first batch of mRNA shots. The contract will generate well over $9 billion for Pfizer, as this latest purchase agreement tops off at 300 million doses. Compared to previous settlements with Pfizer, this public-private no-bid arrangement will come at a much higher cost to the U.S. taxpayer.

The Biden Administration has justified the deal by claiming that it needs to restock supply to prepare for seasonal spikes. The data does not support such a claim. According to the CDC, almost 100 million taxpayer-funded Pfizer shots (and 169 million total shots) have gone unused, resulting in billions of dollars in waste.

The new arrangement allows for the Biden Administration to buy Pfizer’s authorization-pending COVID injections, which the company claims is reformulated for newer variants.

However, even the new formulation is already outdated. It was designed and trialed for an Omicron subvariant (BA.1) that was popular last Winter, but no longer exists in circulation, potentially rendering it just as useless as the Wuhan strain shot. The deal includes the infant and toddler formulations, which are based on the non-existent Wuhan strain.

None of the shots for this deal will be supplied under an FDA approved label. Instead, they will be distributed under emergency use authorization (EUA). Pfizer has never deployed its FDA-approved vaccine in the United States. The company recently acknowledged that it never intends on producing its original FDA approved vaccines.

The original deal with Pfizer was negotiated by the Trump Administration during the days of Operation Warpspeed. It paid the pharma giant $19.50 a dose. The new pact gives Pfizer $30.48 per dose, resulting in an astronomical 56% hike from the deal negotiated by the last administration.

The price hike conflicts with the probability that Pfizer’s costs are likely much lower than they were with the original purchase order. The infant and child shots have a fraction of the active agreement as the adult supply, and each vial stores more doses . Moreover, Pfizer has added an ingredient to the formula that allows for a significant shelf life extension, making the logistics much more cost effective.

Pfizer’s margins were already through the roof prior to the Wednesday announcement.

Pfizer’s May earnings report showed that the company logged a record breaking $26 billion in Q1 sales, marking a quarterly profit of $7.86 billion. Revenue was up 77% from 2021, while profit was up 61%. Now absorb these 2022 numbers in the context of Pfizer’s 2021 revenue outperforming its 2020 revenue by 95%.

Before the new vaccine purchase order, Pfizer was already on track to bring in over $100 billion in revenue and $32 billion in net income this year. In financial statements, the company has acknowledged that it has transformed itself into a COVID-19-driven business. All of its new income is coming from the American taxpayer and other government “customers” via their taxpayers, who have virtually no say in the matter. [MORE]

Judge Orders the Government of Uruguay and Pfizer to Turn Over Documents as Court Considers Request to Halt COVID Injections for Kids

From [CHD] Uruguayan government officials and Pfizer on Wednesday appeared in court after a judge gave them 48 hours to present detailed information on Pfizer’s COVID-19 vaccine while the court considers an injunction request to halt COVID-19 vaccinations for children 5 and older.

Judge Alejandro Recarey of the Administrative Litigation Tribunal used his inquisitorial powers to demand the Uruguayan Ministry of Public Health, State Health Services Administration and the President’s Office submit all information regarding the contracts for the purchase of COVID-19 vaccines, including contractual information related to any clauses of civil indemnity or criminal impunity of the suppliers in the event of adverse effects.

According to a court order released on Saturday, Judge Recarey ordered Pfizer and government officials to:

  • Provide full and unredacted, certified copies of “each and every one of the purchase contracts (as well as any other related negotiation agreement), of the so-called anti-COVID vaccines that you have signed, own or are simply within your reach.”

  • Explain whether “these instruments” contain clauses of “civil indemnity and/or criminal impunity of the suppliers regarding the occurrence of possible adverse effects.”

  • Provide extensive detail about the biochemical composition of “so-called vaccines against SARS-CoV-2 in supply to the national population, especially the one aimed at children.”

  • Explain if the “different doses are distributed in batches or differential (different) items,” and if so, “clarify for what reason, and based on what criteria, each would be provided to different population levels, whether the drugs in each batch are diverse by their content and how and for whom they would be distinguishable. If it “turns out to be the real existence of different lots,” doses of each are “requested for judicial expert examination.”

  • Specify if the “so-called vaccines” contain messenger RNA by explaining, if necessary, what that means. Explain what “therapeutic or extra therapeutic consequences — adverse or not — [mRNA] can have for the person inoculated with it. It must be specified with regard to the latter, and in a negative hypothesis in terms of alleged damages, if there is indeed — with scientific rigor — the possible safety of the messenger RNA, or if there is simply a lack of information on the point.”

  • State “very specifically and beyond what has been inquired, it is requested that it be said if it is known to you that those labeled as vaccines contain or may contain nanotechnological elements. Clarifying, if not, whether such a temperament would arise from an effective verification of its absence, or from mere ignorance of the components of the referred ‘vaccinal’ substances.”

  • Certify whether the substances contained in the “so-called vaccines” supplied in Uruguay are experimental or not. That is, “explain in full and detail whether they are approved by the U.S. Food and Drug Administration (FDA), or equivalent body, according to the usual protocols, or if they have some other type of emergency permission.” If this is the case, explain “granted by whom and with what guarantees and based on what regulations.”

In short, you “must also respond if you are aware that either the manufacturer and/or supplier, or any academic or governmental body (domestic or foreign), have admitted — in any way that may be — the experimental nature of the aforementioned vaccines.”

  • Present complete and up-to-date information in your possession about “what is scientifically known — and what is not known — about the effectiveness of those labeled as vaccines” and their possible short, medium and long-term adverse effects.

  • “Provide official figures that demonstrate the negative or positive incidence of so-called vaccination in the number of infections and deaths diagnosed with COVID from the beginning of the campaign to date.”

  • State whether “studies have been carried out to explain the noticeable increase in deaths for COVID-19 since March 2021 or if information is in your possession — with sufficient scientific support and evidence — about it.”

  • Provide information on the total number of deaths in Uruguay due to COVID-19 since the beginning of the “so-called pandemic,” the global average age and how many were for “COVID-19 in an exclusive causal relationship” and how many were “with COVID-19” — that is, with the presence of the virus, but was not the main cause of death.

  • “Demonstrate scientifically — with evidence of national or international studies that have been done — whether the status of non-vaccinated poses a health hazard to the entire population or third parties.“

If it is the case, two other things will be required: the determination and demonstration of the degree of danger, and the reason that explains why, if this were eventually the case,” vaccination would not have been mandated. Prove whether both the vaccinated and unvaccinated infect equally. If they do not, explain what this would be like and in what proportions — and prove what is stated.

  • Clarify the reasons for the “lack of preview informed consent, in relation to the act components of what the government itself presents as a vaccination campaign.”

  • “Detail, with first and last names, the identity of the professional technicians who have directed and direct the aforementioned campaign, or anyone who has provided advice at any level.”

Also provide relevant data for their location “for their judicial interrogation, adding to the required information, data about whether any of them are part of any foreign governmental or para governmental organization, or they have worked for one of them in any way, or, where appropriate, manage in a multinational company” focused on healthcare. “Detail, if necessary, the personal names and organizations or companies involved.”

  • Explain if alternative therapies for COVID-19 have been studied for any variants. If not, clarify why those were not explored. “If positive, give the research results — giving an account of whether those were used in Uruguay or not.”

For the latter option, provide the reasons that would have been taken to discard the use of alternative therapies, adding whether or not “you know that they have been used in other countries successfully, still relative, or not.”

The order also required Pfizer to state within 48 hours whether it has “admitted, in any area, internal or external to it and its partners, the verification of adverse effects” of its COVID-19 vaccines in children.

“I applaud Uruguayan judge Recarey for posing many tough questions to Pfizer over its COVID shots and the contracts it imposed on Uruguay,” Mary Holland, president of Children’s Health Defense (CHD), told The Defender in an email.

“From the beginning, Pfizer has hidden its data and liability-free contracts to avoid liability from the shots,” Holland said.

She explained:

“Many countries, including those in Latin America, have relied on U.S. regulatory agencies in the past to guide health policy. But the U.S. regulatory bodies have failed regarding COVID.

“There is no scientific or ethical justification to authorize COVID shots for children, as some countries, including Denmark, now acknowledge. We know that children are at almost zero risk of dying from COVID. The FDA has extended Emergency Use Authorization for the Pfizer-BioNTech vaccine while illegitimately ‘approving’ Comirnaty, thus engaging in a fraudulent ‘bait-and-switch’ scheme to avoid all liability while hawking ‘approved’ vaccines.”

Holland said CHD is currently pursuing two lawsuits against the FDA for its arbitrary and capricious decisions on COVID-19 shots, and she is “pleased to see that other countries are stepping into the scientific and legal breach.”

“I hope Pfizer complies with the judge’s order, but given its long criminal rap sheet, it remains to be seen,” Holland added.

Although Judge Racarey took it upon himself to review data presented by Pfizer and government officials on COVID-19 vaccines, Uruguay is one of 47 co-sponsoring countries that agreed to the Biden administration’s amendments to the World Health Organization’s (WHO) 2005 International Health Agreements that attempted to place member states’ health sovereignty in the hands of WHO Director-General Tedros Adhanom Ghebreyesus and its regional directors. [MORE]

76 UK Doctors Sign Open Letter to Government Warning Against COVID Injections

From [HERE] A group of 76 physicians have penned an open letter to Her Majesty’s government warning against following in the footsteps of the United States, whose Food and Drug Administration (FDA) approved COVID-19 vaccines for children as young as six months. 

The letter, posted by world-renowned scientist Dr. Robert Malone, began by saying that the “balance of benefit and risk” in administering the vaccine to small children is “totally inappropriate”, citing the very low risk and very high immunity young children have. 

Then the physicians attacked Pfizer’s documentation used to convince the FDA to allow small children to be vaccinated. 

To begin with, “the protocol was changed mid-trial. The original two-dose schedule exhibited poor immunogenicity with efficacy far below the required standard. A third dose was added by which time many of the original placebo recipients had been vaccinated.” 

Second, no statistical significance was found between the placebo groups and vaccinated groups, and the results were based on only three participants in the younger age group, and seven in the 2-4-year-olds. 

Third, the calculated vaccine efficacy is only 15%. 

The letter also added that in the immunogenicity studies against Omicron, only 66 children were tested a full month after the third dose. 

“It is incomprehensible that the FDA considered that this represents sufficient evidence on which to base a decision to vaccinate healthy children,” wrote the physicians. They highlighted other gaps in Pfizer’s research, and noted that countries like Sweden, Holland and Norway are not injecting small children who have had COVID-19. 

The meticulously sourced letter cited several studies and data to build a case based on a) the extremely low risk from COVID-19 in young children; b) the vaccine’s low efficacy; c) the potential harms of the vaccines, drawing data from Pfizer’s own study; d) the lack of informed consent which “borders on misinformation”; and e) the effect on public confidence when the government pushes a COVID-19 vaccine instead of those “against much more serious diseases, such as polio and measles.” 

“Pushing an unnecessary and novel, gene-based vaccine on to young children risks seriously undermining parental confidence in the whole immunization program.” 

Furthermore, the “poor quality of the data presented by Pfizer” risks undermining public confidence in regulators and the pharmaceutical industry. 

The physicians also took a swipe at the vaccine for older children: 

“In older children, for whom the vaccines are already licensed, they have been promoted via ethically dubious schemes to the potential detriment of other, and vital, parts of the childhood vaccination program.” 

“For a tiny minority of children for whom the potential for benefit clearly and unequivocally outweighed the potential for harm, vaccination could have been facilitated by restrictive licenses,” the letter concluded. “Whether following the precautionary principle or the instruction to First Do No Harm, such vaccines have no place in a routine childhood immunization program.”